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ABSTRACT

THE ROLE OF MOTIVATION TO CHANGE IN THE TREATMENT OF
OBSESSIVE-COMPULSIVE DISORDER
SEPTEMBER 2009
CHRISTOPHER M. SPOFFORD, B.A., UNIVERSITY OF NEW HAMPSHIRE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Richard P. Halgin

The primary purpose of this study was to examine the role of motivation in the treatment
of individuals hospitalized for severe OCD, specifically, the extent to which an
individual’s motivation for treatment and motivational orientation (intrinsic or extrinsic
motivation) predict OCD treatment response. The sample consisted of 142 individuals
diagnosed with severe treatment-refractory OCD participating in an intensive treatment
program. Patients completed a measure assessing overall motivation and motivational
orientation at admission (TSRQ), and measures assessing depressive severity (BDI) and
OCD symptom severity (Y-BOCS) at admission and discharge. Hierarchical multiple
regression analyses were performed in which admission levels of overall motivation,
intrinsic motivation, and extrinsic motivation were examined as predictors of OCD
treatment response when controlling for length of treatment and baseline levels of OCD
and depressive symptoms. Results indicate that a high initial level of extrinsic motivation
was associated with poorer treatment outcome when controlling for other variables.
Furthermore, findings suggest intrinsic motivation appears to have an interactive effect
v

with OCD symptom severity, such that a high level of intrinsic motivation at the outset of
treatment may predict positive treatment outcome when OCD symptoms are more severe.
Overall initial level of motivation was not found to be a significant predictor of OCD
treatment outcome. Treatment implications and suggestions for future research are
discussed.
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CHAPTER 1
INTRODUCTION

The psychological treatment of obsessive-compulsive disorder (OCD) has
emerged as a story of relative success within the field of mental health. Prior to the
1970s, the prognosis for individuals suffering from OCD was considered poor. The
consensus among clinicians was that OCD was an unmanageable condition with an
unrelenting course that was largely unresponsive to treatment (Abramowitz, 2006). This
bleak prognosis has changed drastically over the past two decades. The development and
application of effective cognitive-behavioral interventions, specifically exposure and
response prevention (ERP), has led to much higher rates of treatment success and positive
outcomes in the management of OCD. ERP is now widely recognized as the “gold
standard” for effective OCD treatment and is supported by a considerable amount of
empirical outcome research (e.g., Franklin, Abramowitz, Kozak, Levitt, & Foa, 2000).
The efficacy of ERP for OCD has been well documented (e.g., Abramowitz,
1998), with response rates ranging from 63% (Stanley & Turner, 1995) to 90%
(Abramowitz, 1997) for individuals who undergo a full course of treatment. However,
despite the effectiveness of ERP, many OCD sufferers have not benefited from ERP
treatment. Researchers estimate that among those who comply with ERP treatment 10%
or more do not respond (Vogel, Bjarn, Stiles, & Gotestam, 2006). Moreover, because of
the demanding and difficult nature of the treatment, many individuals refuse to
participate in such an intervention. Refusal rates, in which OCD sufferers turn down
available ERP treatment, are generally estimated at approximately 25-30% (Franklin &
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Foa, 1998; Kozak, Liebowitz, & Foa, 2000). In addition, among those individuals who
begin ERP, many demonstrate poor compliance to the prescribed therapy, which is a
predictor of overall poor response (Araujo, Ito, & Marks, 1996; Fama & Wilhelm, 2005).
Furthermore, many patients drop out of treatment altogether, with estimates as high as
40% (Kozak et al., 2000).
Despite the evidence of treatment resistance and refractoriness for OCD, little
research has been conducted to identify the correlates of treatment non-response and
dropout. Much of the research on this topic has focused on identifying sub-types of
individuals with OCD who are less responsive to behavioral interventions (e.g., Alonso et
al., 2001; Ball, Baer & Otto, 1996; Mataix-Cols, Marks, Greist, Kobak & Baer, 2002).
Individuals with certain primary symptom presentations have been identified as less
amenable to ERP treatment including compulsive hoarding (Abramowitz, Franklin,
Schwartz, & Furr, 2003) and symptoms involving sexual/religious obsessions (MataixCols et al., 2002). This information is useful given that OCD is a heterogeneous
condition; however, other correlates that are recognized as predictors of success in other
forms of therapy and for other conditions have yet to be examined in the treatment of
OCD. The role of motivation for treatment as a correlate has not yet been explored. The
paucity of research on the relationship between motivation and ERP treatment is
surprising given the demanding nature of this type of therapy.
The goal of this study is to examine the relationship between motivation for
treatment and OCD treatment response in individuals receiving intensive residential
treatment for treatment-refractory OCD. The hope is that the exploration of this
relationship will lead to empirically based knowledge that will inform future treatments.
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More specifically, by investigating the role of motivation in OCD treatment response we
may uncover knowledge leading to more effective therapeutic techniques for treating
individuals who do not respond to conventional OCD treatments. In the following
sections, I introduce the diagnosis of OCD and describe conventional therapies generally
associated with this disorder. Then I discuss the concept of motivation and the role it
plays in the process of therapy and behavior change, including a brief consideration of
Deci and Ryan’s (1985) Self-Determination Theory (SDT) and how this theoretical
perspective informs current conceptualizations of OCD treatment response. Finally, I
enumerate the four research questions used in the present project to study the role of
motivation in OCD treatment response.

Description of OCD
Obsessive-Compulsive Disorder is defined in the DSM-IV-TR as an anxiety
disorder characterized by the presence of obsessions and/or compulsions (American
Psychiatric Association, 2000). OCD is estimated to occur in about 2.5% of the
population, and it is the fourth most common psychological disorder after depression,
substance abuse, and phobias (Narrow, Rae, Robins, & Regier, 2002). For individuals
who do not participate in treatment, the lifetime course of OCD is chronic and
deteriorating, with symptoms waxing and waning as a function of general life stress
(Abramowitz, 2006).
Obsessions are persistent and intrusive thoughts, ideas, impulses, or doubts that
cause the individual considerable distress and anxiety. Obsessions are highly specific to
the individual; however, researchers have identified some common themes including
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aggression and violence, over-concern with causing harm to others, sex, religion, need for
symmetry or completeness, and anxiety regarding serious illnesses (Abramowitz,
Franklin, Schwartz, & Furr, 2003). Although most individuals with OCD experience
several types of obsessional thoughts, some focus on a particular fear such as contracting
AIDS which preoccupies their day-to-day thinking.
Compulsions are the urges to perform behavioral or mental rituals aimed at
reducing the discomfort, anxiety, or doubt brought on by obsessive thoughts.
Compulsions tend to be deliberate, yet senseless and excessive with respect to the fear or
discomfort which they are intended to neutralize. Similar to obsessions, compulsions
tend to be idiosyncratic. Some common compulsive behaviors include repetitive and
excessive hand washing, checking (e.g., locks, stoves, electrical devices, etc.), counting,
excessive prayer, and repetitive uttering of phrases to neutralize fears or doubt.
Treatment for OCD often targets these compulsions in an attempt to limit the amount that
they are relied upon to reduce the individual’s level of anxiety.
OCD is unique among the emotional disorders in that the form and content of its
symptoms are idiosyncratic and can vary widely from one individual to the next. In fact,
two individuals with OCD may present with completely non-overlapping symptoms.
Such heterogeneity in symptom presentation necessitates a thorough topography of the
patient’s symptoms: the types of obsessions and compulsions that are present and the
severity of these symptoms (Abramowitz, 2006). To establish a diagnosis of OCD,
structured and semi-structured interviews along with self-report instruments are
frequently used. One common instrument used to assess the presence and severity of
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OCD symptoms is the Yale-Brown Obsessive Compulsive Scale or Y-BOCS (Goodman,
Price, Rasmussen, Mazure, Delgado et al., 1989).

Exposure and Response Prevention (ERP)
Cognitive-behavioral therapy involving exposure and response prevention
techniques is now considered to be the gold standard of treatment for OCD (Abramowitz,
2006). The aim of ERP is to allow individuals with OCD to experience repeated
situations in which they are confronted with fearful stimuli that trigger obsessions and
distress (exposure), while refraining from engaging in rituals or behaviors normally used
to decrease this distress (response prevention). ERP treatment is based on basic
behavioral learning principles of extinction and habituation, largely pioneered by Meyer
and associates (Meyer, 1966; Meyer & Levy, 1973), in which fears and anxiety tend to
lessen and extinguish after repeated exposure to a stimulus. This experience is akin to
someone learning to dive into deep water in a swimming pool. At first, the act is aversive
and anxiety provoking; however, after repeated exposure and attempts, the individual
gains mastery and the act provokes less fear and anxiety.
The exposure portion of ERP therapy can occur in one of two ways. The
individual with OCD can be encouraged to confront the fearful stimuli in low-risk
situations (in vivo exposure) or the individual can be encouraged to imagine situations
that are aversive and fearful (imaginal exposure). For example, a man who is fearful that
he may have hit someone with his car may engage in the ritual of repeatedly checking in
his rearview mirror and stopping his car after driving over crosswalks. This individual
may go as far as to avoid more direct car routes and instead take alternate routes that have
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a lower incidence of crosswalks. A therapist employing ERP techniques to treat this
individual might encourage the man to drive the more direct route and experience the
anxiety that accompanies this behavior.
The response prevention portion of ERP treatment is equally important to the
overall success of OCD treatment due to the fact that, if the individual is allowed to
perform rituals during the exposure session, then the learning experience is shortcircuited. More specifically, the goal of ERP is to help the client realize that feared
situations in which they obsess over are often not truly as dangerous as they believe, and
that anxiety can subside on its own without the help of compulsive rituals or avoidance.
For example, if the man who is fearful of hitting someone with his car while driving over
crosswalks is allowed to stop the car and check after driving over crosswalks, then he
would not experience the full brunt of the anxiety that is associated with continued
driving. In this respect, the client would continue to use this compulsive behavior as an
“emotional crutch” to decrease anxiety. Therefore, a therapist working with this
individual may encourage or “coach” the client during ERP sessions to resist the urge to
pull over the car and compulsively check the street. Thus, successful ERP requires the
client to remain in an exposure situation until the obsessional distress decreases on its
own, without the client attempting to reduce the distress by withdrawing from the
situation or performing compulsive rituals or neutralizing behaviors.

Treatment Motivation
Although there is ample evidence supporting the effectiveness of cognitivebehavioral therapy in treating people with OCD, there is still substantial evidence that
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many people with OCD do not benefit fully from this intervention. For example, a
sizable percentage of patients fail to comply with their therapeutic regimen, drop out of
treatment prematurely, or encounter difficulty in maintaining therapeutic gains (Vogel et
al., 2006). The study of motivation is an area of psychology that has particular relevance
to the issues of dropout, compliance, and maintenance of change. In fact, lack of
motivation is one of the most frequently cited reasons for patient dropout, failure to
comply, frequency of relapse, and other negative treatment outcomes for a variety of
psychotherapeutic interventions (Pelletier, Tuson, Haddad, 1997; Ryan, Plant, &
O’Malley, 1995).
It has been well established that a client’s motivation level is a pivotal factor in
psychological treatment (Drieschner, Lammers, van der Staak, 2004). As Krause (1966),
one of the first researchers to explore this topic, stated, “Because the psychotherapy
patient, the counseling patient, or the casework client does not merely receive treatment
but must actively participate in it, his motivation to participate is a vital factor in the
outcome of treatment” (p. 9). The importance of treatment motivation is reflected in the
growing interest and attention from the field of psychology over the past 25 years.
Authors of numerous empirical studies and theoretical articles have examined the
relationship between treatment outcome and motivation. For the most part, the bulk of
this literature has focused on treatment of substance abuse and addiction (e.g., Erickson,
Stevens, McKnight, & Figueredo, 1995; Gerdner & Holmberg, 2000; Miller & Rollnick,
2002; Ryan et al., 1995). There has also been some research conducted on treatment
motivation as it relates to other psychological difficulties including individuals suffering
from eating disorders (Feld, Wooside, Kaplan, Olmsted, & Carter, 2001; Geller, 2002;
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Touyz, Thornton, Rieger, George, Beumont, 2003; Vansteenkiste, Soenens,
Vandereycken, 2005), and sexual offenders (Tierney & McCabe, 2001, 2002; Vanhoeck,
2001). Furthermore, a tremendous amount of research and theory has focused on the
importance of matching treatment interventions to the client’s level of motivation (e.g.,
DiClemente, 1999; Miller & Rollnick, 1991; Prochaska, DiClemente, & Norcross, 1992;
Prochaska & Norcross, 2002).
Despite the growing interest in motivation as it pertains to treatment outcome,
motivation continues to remain an ambiguous concept (Drieschner et al., 2004).
Historically, the phrase treatment motivation has been used in a number of contexts in the
psychological literature. For individuals who have not yet entered therapy, treatment
motivation may refer to preliminary treatment-related behaviors such as the act of seeking
or entering treatment. However, for individuals who are already participating in therapy,
treatment motivation may refer to the client’s level of engagement and compliance with
the prescribed therapy. Some researchers on this topic use the former definition (e.g.,
Gerdner & Holmberg, 2000; Pelletier, Tuson, Haddad, 1997) while other researchers use
the latter (e.g., Isenhart, 1994). Miller and Rollnick (1991), two leading researchers in
the field, define motivation as “the probability that a person will enter into, continue, and
adhere to a specific change strategy” (p. 19). For the purpose of this study, Miller and
Rollnick’s definition of motivation (i.e., initiating and adhering to a change strategy) was
used when subsequently referring to the patient’s motivation for treatment.
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Self-Determination Theory: Intrinsic and Extrinsic Motivation
One theoretical perspective on motivation that has received considerable attention
from researchers over the last two decades is self-determination theory (SDT) proposed
by Deci & Ryan (1985). SDT focuses on the quality or nature of the motivation guiding
behavior. Deci and Ryan first proposed SDT in 1985; since that time this theory has
undergone considerable investigation and development with numerous empirical studies
providing support for the theory. SDT may contribute to an understanding of
psychotherapy effectiveness for the following reasons. First, SDT distinguishes between
different subtypes of motivation, or motivational orientations, which impact the
maintenance and integration of therapeutic change. Second, SDT presents clear
hypotheses regarding the therapeutic conditions that can hinder or facilitate a client’s
motivation to change. Third, SDT outlines specific consequences (i.e., cognitive,
affective, and behavioral) associated with different types of motivation. Fourth, SDT
addresses the issue of internalization, the process in which therapeutic changes that are
reinforced by external sources (e.g., the therapist) become integrated into the individual
and become a part of his or her thoughts, beliefs, and self-schema (Pelletier et al., 1997).
When Deci & Ryan (1985) developed SDT, they proposed three basic types of
motivation which regulate behavior: intrinsic motivation, extrinsic motivation, and
amotivation. Over the course of the past 30 years, Deci and Ryan have elaborated on
these concepts. People engage in intrinsically motivated behaviors purely for the
satisfaction derived from their performance, such that behaviors are performed
voluntarily and in the absence of any material rewards or external constraints. For
example, a socially phobic woman who decides independently to enter therapy to gain
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mastery over her fear of speaking in public is exhibiting intrinsic motivation. With
intrinsic motivation, the assumption is that the individual’s actions are fully autonomous,
self-determined and self-initiated (Ryan & Deci, 2000). In the realm of social
psychology and attribution theory, theorists relate the concept of intrinsic motivation to
the attributions people make regarding their perceived locus of causality (Ryan & Deci,
2000). Perceived locus of causality refers to the degree to which people experience their
behavior as self-initiated or self-chosen rather than pressured or coerced by external
forces. Therefore, an individual who experiences a more internal locus of causality would
be expected to be more intrinsically motivated contingent on the context of the situation
(Vansteenkiste et al., 2005)
The relationship between intrinsic motivation and positive outcomes has been
well documented in a number of research domains including education, sports,
employment, and health (see Deci & Ryan, 2002; Deci & Vansteenkiste, 2003; Ryan &
Deci, 2000). For example, studies have demonstrated that a higher level of intrinsic
motivation is associated with more positive outcomes in health domains including
adherence to smoking cessation programs (Williams et al., 2006) and adherence to
dietary guidelines for individuals diagnosed with diabetes (Senecal, Nouen, & White,
2000).
Several psychotherapy researchers also emphasize the importance of intrinsic
motivation. Miller and Rollnick (1991) developed Motivational Interviewing (MI), a
commonly used therapeutic approach for treating people with substance abuse problems.
Clinicians using MI focus the intervention on the process of promoting intrinsic
motivation. Miller and Rollnick (2002) describe the MI intervention as “a client-
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centered, directive method for enhancing intrinsic motivation to change by exploring and
resolving ambivalence” (p. 25). MI uses a cluster of principles and therapeutic
techniques to increase intrinsic motivation in patients, including techniques such as
taking a non-judgmental stance, expressing empathy, exploring ambivalence fully,
developing discrepancy, avoiding confrontation, and supporting self-efficacy (Miller,
Rollnick, & Conforti, 2002). Similarly, in developing the Transtheoretical Model of
Change (TMC), Prochaska and DiClemente (1982) placed emphasis on identifying the
individual’s internal (or intrinsic) versus external (or extrinsic) motivations in order to
assess stage of change and readiness for change. According to DiClemente (1999),
clinicians can help patients reach higher stages of change and increase treatment
readiness by helping them increase their internal versus their external motivations to
change. Both MI and TMC have had lasting impact on the field of psychotherapy and
have become influential theories in various health-related domains (Hettema, Steele &
Miller, 2005; Prochaska & Norcross, 2002).
Given the established relationship between intrinsic motivation and positive
outcomes in a number of health domains including psychotherapy (Deci & Vansteenkiste,
2003; Pelletier, Tuson, Haddad, 1997), one would expect that this relationship might also
exist in the treatment of OCD; namely, individuals who exhibit a higher level of intrinsic
motivation would have better treatment outcomes in intensive treatment for OCD.
Furthermore, given that ERP, the conventional therapy for OCD, involves continuously
confronting aversive stimuli that cause the patient distress, one would expect that
intrinsic motivation would be an essential component to compliance and treatment
success.
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Although extrinsic motivation has also been viewed in the literature as a factor in
treatment outcome, its role in the outcome process is complex. In contrast to intrinsic
motivation, extrinsic motivation is a process by which one is motivated by external
factors. Deci and Ryan (1985) identified four subtypes of extrinsic motivation, which
they classified along a continuum from less self-determined to more self-determined.
These four subtypes of extrinsic motivation from lowest to highest level of selfdetermination are: external regulation, introjected regulation, identified regulation, and
integrated regulation.
External regulation refers to behaviors that are controlled by external forces such
as material rewards or constraints placed on someone. In other words, the individual
does not perform the behavior for its own sake, but rather performs the behavior to
receive a reward or avoid punishment (Deci & Ryan, 1985). For example, a client who
enters therapy for OCD because his wife has given him an ultimatum to either deal with
his OCD symptoms or she will file for divorce is considered to be motivated by external
regulation. Another example of external regulation might be a man who engages in
compulsive hoarding, and enters therapy after his boss has mandated that he de-clutter his
workspace or face termination.
Introjected regulation is a form of extrinsic motivation with a slightly different
mechanism. With introjected motivation, the formerly external source of motivation has
been internalized such that its actual presence is no longer needed to initiate or maintain a
behavior. Instead, behaviors are reinforced through external pressures and emotions such
as guilt, anxiety, and responsibility to others. An example of introjected regulation would
be a mother who enters treatment for OCD because she feels tremendous guilt about
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inadvertently modeling her irrational behavior to her young child. Another example
would be a man who enters OCD treatment because he feels his symptoms have caused
him to be an ineffective husband and father. In both instances, the behavior is thought to
be extrinsically motivated because of internal pressures such as feelings of shame and
guilt. Although these emotions arise within the person, these motivational forces are
thought to remain external to the person’s self, because the person may not fully and
freely endorse them (Deci & Ryan, 1995). Therefore, in the abovementioned example,
the man seeking therapy for his OCD might not fully “own” the intention to change and
may make statements such as, “I am getting treatment so that this doesn’t affect my
children anymore;” or “My wife has put up with my OCD for too long.”
Identified regulation is a behavior that is performed because it is congruent with a
person’s values or goals (Deci & Ryan, 1985). For example, a woman may seek therapy
for OCD because she believes that she is failing to perform up to the level of others in the
workplace or the expectations of her boss. In this example, the treatment is still sought
for extrinsic reasons (e.g., to achieve expectations); however, it is more internally and
self-determined than the previous two forms of extrinsic motivation mentioned.
Integrated regulation refers to behaviors that are performed not only because the
individual values their significance but also because it is now consistent with some of the
individual’s self-schemas and identity. This type of motivation is the most fully selfdetermined type of extrinsic motivation. An example of a statement from an individual
with this motivational orientation might be: “I entered treatment for OCD because I
wanted to save my marriage and become a better father, but now I feel that it is important
to take care of one’s mental health at all times.” This statement reveals that, although this
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individual’s behavior was initially less self-determined, he has now identified with the
self-schema of maintaining his psychological health. On the continuum of extrinsic
motivation, integrated regulation would be the form of extrinsic motivation considered
most similar to intrinsic motivation.
Deci and Ryan (2002) also discuss the construct of amotivation . Whereas the
concepts of extrinsic motivation and intrinsic motivation describe the quality of
motivation, amotivation refers to the phenomenon in which individuals do not perceive a
relationship between their actions and the outcomes that follow their actions. This
phenomenon is exemplified by someone engaging in an activity with no understanding as
to why, or without any sense of real purpose (Pelletier, Tuson, & Haddad, 1997). For
example, a man may enter OCD treatment believing that his situation is hopeless and that
therapy will undoubtedly prove to be a waste of time and energy. As with extrinsic
motivation, researchers have demonstrated that amotivation is associated with poor
treatment outcomes including higher rates of dropout and non-compliance (Long,
Williams, Midgely, & Hollin, 2000; Pelletier, Tuson, & Haddad, 1997; Senecal et al.,
2000).
Deci and Ryan (1985) proposed that motivation is a dynamic concept. Other
researchers on motivation have also endorsed this idea (Miller & Rollnick, 2002;
Prochaska and DiClemente, 1992). In other words, patients entering therapy may start
out with one motivational orientation and move to another type of motivation as the
therapy progresses. Miller and Rollnick’s (2002) Motivational Interviewing techniques
are based on the idea that therapeutic change occurs by “enhancing intrinsic motivation
by exploring and resolving ambivalence” (p. 25). Other theorists have taken a slightly
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different approach in describing the mechanisms of motivation and change in therapy.
Vansteenkiste & Sheldon (2006) postulate that it is unlikely that MI enhances intrinsic
motivation, as few patients are intrinsically motivated to begin therapy. Instead, they
propose that therapeutic techniques promote a greater indentified or integrated motivation
for change. From this perspective, therapy is not about enhancing the individual’s
intrinsic motivation to change, but rather it is about enhancing the client’s internalization
and identification with the extrinsic change intentions. For example, a client may start
OCD treatment at the urging of his wife with the purpose of saving their marriage;
however, as the therapy progresses his motivation may shift to a more internalized and
self-identified orientation. Although he may have previously regarded treatment as a way
to save his marriage, now he may think of therapy as a way to improve his mental health
and feel better about himself. This motivational shift may also improve the treatment
process, in that the client now approaches therapeutic tasks with a sense of selfendorsement rather than with a sense of pressure or resistance.

Motivation, Depression, and OCD
Individuals suffering from OCD comprise a heterogeneous group. Research has
demonstrated that OCD is frequently co-morbid with a variety of Axis I and Axis II
psychological disorders, particularly mood and anxiety disorders (e.g., Steketee, Eisen,
Dyck, Warshaw, & Rasmussen, 1999; Steketee, Henninger, & Pollard, 2000). At least
one-third of individuals with OCD also present with major depression, and many more
have clinically significant depressive symptoms (e.g., Rasmussen & Eisen, 1998;
Steketee, Chambless, & Tran, 2001). This co-morbidity is significant given that it may

15

influence the patient’s ability to engage in and complete behavioral treatment. In general,
studies have demonstrated that patients with multiple, co-morbid conditions present a
pattern that is more severe and more difficult to treat than “pure presentations” of
disorders (Abramowitz & Foa, 2000; Mineka, Watson, & Clark, 1998; Steketee,
Chambless, & Tran, 2000). In fact, the common occurrence of co-morbid depression
with OCD presentations has led some researchers to advocate for more comprehensive
assessment of depressive symptom severity with tools such as the Beck Depression
Inventory or BDI (Abramowitz, 2006).
The issue of co-morbidity becomes particularly relevant when considering the
effects of depression on levels of motivation for OCD treatment. Anhedonia and low
levels of motivation have been well documented in the literature regarding depression.
Individuals with major depression commonly exhibit symptoms of loss of interest, loss of
energy, and loss of motivation (Clark and Watson, 1991; Watson and Clark, 1995).
Clinically, such symptoms could interfere with ERP treatment for OCD, particularly
given the fact that this treatment requires the difficult task in which patients must face
aversive and fear provoking stimuli. For instance, a patient presenting with significant
depression may be less hopeful that treatment will be effective and thus be less motivated
to comply with the therapist’s recommendations. Likewise, the anergia and fatigue
associated with depression may impede therapeutic progress despite the best intentions of
the patient and therapist (Carmin, Wiegartz, & Wu, 2005). Given the relevance of
depressive symptoms to motivation, this study investigated and evaluated the role of
depression as it relates to motivation for OCD treatment.
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Motivation and the Treatment of OCD
Although most clinicians and researchers recognize the importance of motivation
in determining treatment outcome, few empirical studies have examined the role that
motivation plays in the OCD treatment process. Initial studies examining the relationship
between motivation and treatment outcome for anxiety disorders involved trials with
psychotropic medication. Studies investigating treatment response to benzodiazepine
medication for panic disorder (Bietman et al., 1994), and generalized anxiety disorder
(Wilson, Bell-Dolan, & Bietman, 1997) were the first to examine the role of motivation
and readiness to change in anxiety-related disorders. Both these medication studies
found that pre-treatment stage of readiness to change was a significant predictor of
anxiety reduction, with patients at the pre-action stage of readiness (i.e., those exhibiting
less motivation for change) experiencing the least amount of reduction in anxiety
symptoms with medication treatment. These preliminary studies on the role of motivation
in the treatment of anxiety have led some researchers to advocate motivational
enhancement techniques aimed at maximizing efficacy for other empirically supported
psychotherapeutic interventions (e.g., Foa, 2000; Miller & Rollnick, 2002; Prochaska,
2000).
Based on the assumption that motivation must play an integral role in successful
treatment of anxiety and depression, some clinical researchers have begun to explore the
effects of augmenting traditional CBT treatment with Motivational Interviewing
techniques (Arkowitz & Westra, 2004; Westra, 2004; Westra & Phoenix, 2003). These
initial case studies have reported on the implementation of motivational enhancement
techniques with patients who have not responded to traditional CBT treatment. These
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case-based alternative interventions were conceptualized using the Stages of Change
Model (Prochaska, 2000), in which interventions were matched to the client’s specific
level of readiness to change.
Westra and Phoenix (2003) demonstrated the effectiveness of MI as an
augmentation to conventional CBT treatment for anxiety. They presented two cases, one
of a woman with diagnoses of severe panic disorder and generalized anxiety disorder and
the other case involving a man with severe social phobia. In both cases, the patients
presented with significant resistance to change and exhibited limited response to initial
ERP treatments. Therefore, the treating therapist shifted the focus of therapy to a
therapeutic stance which incorporated MI and motivation enhancement techniques. The
case formulation, course of therapy, and method of intervention were detailed in this
article to illustrate the motivation enhancement techniques used by the therapist. The
findings from these initial case studies were mixed, with one individual benefiting
substantially from the motivational enhancement augmentation as evidenced by a
reduction in anxiety symptom severity, while the other individual experienced
significantly less positive response to the MI techniques (Westra and Phoenix, 2003).
These case studies represented the first attempts at exploring the value of motivational
enhancing techniques in augmenting traditional CBT treatment of people with anxietyrelated disorders. Other case studies have demonstrated positive outcomes when
augmenting CBT with MI techniques for the treatment of anxiety disorders (Arkowitz &
Westra, 2004; Westra, 2004); however, much more research is needed.
Other than the few medication trials, there have been few controlled studies
involving randomized controlled designs to explore the role of motivation in anxiety
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treatment. To date, much of the preliminary research investigating motivation and its
role in psychotherapy for anxiety-related disorders has come in the form of case-based
studies (Arkowitz & Westra, 2004; Westra & Phoenix, 2003). Moreover, the few studies
investigating motivation have focused on examining the efficacy of augmenting
conventional anxiety treatments with MI.
Westra and Dozois (2006) conducted a randomized pilot study of MI for anxiety.
In this study, prior to participating in group cognitive-behavioral therapy, 55 individuals
with a principal anxiety diagnosis (45% panic disorder, 31% social phobia, and 24%
generalized anxiety disorder) were randomly assigned to receive either three pretreatment
sessions of MI adapted for anxiety or no pretreatment (NPT). Participants in the MI
pretreatment group demonstrated greater CBT homework compliance and reported more
control over their anxiety symptoms at the conclusion of treatment as compared to
participants in the NPT group. Furthermore, although participants in both groups
experienced some level of improvement in anxiety symptomatology, the MI pretreatment
group had a significantly higher amount of individuals who were considered CBT
responders at the conclusion of treatment compared to the group that did not receive MI
pretreatment (Westra & Dozois, 2006). The results of this pilot research provide some
evidence that MI may enhance motivation and overall outcome when used to augment
CBT.
Maltby and Tolin (2005) examined the effects of MI for OCD patients who had
initially refused treatment. In this study, 12 patients who expressed ambivalence about
ERP treatment for OCD were randomly assigned to one of two conditions, a readiness
intervention group (RI ) or a waitlist group (WL). Patients in the treatment condition
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were offered a 4-session readiness intervention (RI) which was designed to increase
readiness to change, provide information needed to inform decision-making, and decrease
fears of the ERP treatment. More specifically, participants in the RI group received four
sessions with a therapist who employed motivational interviewing techniques as put forth
by Miller & Rollnick (2002). Prior to the intervention, the investigator made it clear to
patients that no ERP techniques would be employed during the four sessions, and that
subsequent participation in treatment following the RI would be entirely their decision.
Furthermore, innovative techniques were used such as having the client watch a
videotape of an ERP session, encouraging the client to have a phone conversation with an
individual who had undergone this form of treatment, or having the patients create a
sample hierarchical list of fears they might address if they were to enter ERP treatment.
Results of this study indicated a significant beneficial impact for participants in the RI
group as compared to the waitlist condition, with 86% of individuals in the RI condition
and 20% of those in the waitlist condition agreeing to enter treatment after the 4-week
period (Maltby and Tolin, 2005). This finding has implications for the frequent
monitoring of motivation level for this particular subset of OCD sufferers, and provides
evidence in support of the value of readiness interventions for individuals who are less
motivated and more ambivalent regarding action-oriented therapies such as ERP.
However, outcome in this study was measured solely on the qualitative criterion of
whether or not the participant committed to ERP treatment. The investigators did not
make quantitative ratings of motivation level or motivational orientation (intrinsic or
extrinsic motivation). Nevertheless, to date, this is the only study that has empirically
examined the concept of motivation or readiness-to-change as it relates to OCD.
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These few initial investigations have focused exclusively on the application of MI
for anxiety-related issues. No studies to date have investigated levels of motivation for
treatment or motivational orientation (intrinsic or extrinsic) as predictors of treatment
response for anxiety. Furthermore, no study to date has investigated the change in
motivation for treatment over time.

Why Study Motivation to Change in Individuals with OCD?
A substantial gap in the literature exists regarding the relationship between
motivation for treatment and OCD treatment outcome. Researchers and clinicians have
repeatedly emphasized the importance of treatment motivation in determining successful
outcomes, and they point toward a lack of motivation for treatment as a main cause for
dropout, resistance, non-compliance, and non-response (e.g., Foa, 2000). Recently,
researchers have undertaken treatment studies based on the assumption that motivation
plays an important role in treatment response, and they have designed interventions to
increase readiness to change and motivation (e.g., Maltby and Tolin, 2005). However, no
research to date has specifically explored the relationship between motivation for
treatment and response to OCD treatment. More research is needed to explore the extent
to which motivation for treatment is indeed a significant predictor of treatment response.
In conjunction with present efforts to design interventions to increase motivation, more
research is needed to uncover the general mechanisms and pattern of change in
motivation throughout treatment for OCD.
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Research Questions:
This study is the first to investigate the role of motivation as it relates to the
effectiveness of treatment for obsessive-compulsive disorder. Moreover, the majority of
psychotherapy research has examined the role of motivation for treatment as a unitary
construct or in terms of stages of change. This research approach expanded the view of
motivation for treatment to include the often overlooked categories of intrinsic and
extrinsic motivation. Researchers have begun to explore the value of augmenting proven
therapies for anxiety with motivational enhancement interventions and enhancement
techniques (Maltby & Tolin, 2005; Westra & Phoenix, 2003; Westra & Dozois, 2006);
however, these researchers have designed these studies with the assumption that
motivation plays a key role in influencing treatment response. Based on studies in other
health domains, this may well be true. Nevertheless, no studies to date have explored the
specific role motivation plays in OCD treatment response. Furthermore, no studies to date
have investigated the general pattern of change in motivation for treatment of OCD over
time.
This study addressed the following research questions and hypotheses regarding the
role of motivation in the treatment of people with OCD. For the content of questions and
hypotheses, below is a list of each construct and the operationalized measure of that
construct:
1) Total level of motivation: Total score on the Treatment Self Regulation
Questionnaire (TSRQ).
2) Level of intrinsic motivation: Score on the intrinsic subscale of the TSRQ.
3) Level of extrinsic motivation: Score on the extrinsic subscale of the TSRQ.
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4) Level of OCD symptomatology: Score on the Yale-Brown Obsessive
Compulsive. Scale (Y-BOCS).
5) Level of depressive symptomatology: Score on the Beck Depression Inventory
(BDI).
6) OCD Treatment outcome: Score on the Y-BOCS at discharge.
7) Treatment dropout: Leaving the OCDI within two weeks following admission.

Research Question One (Q1). To what extent did initial overall level of motivation for
treatment predict treatment outcome for patients receiving intensive cognitivebehavioral therapy for obsessive-compulsive disorder in a residential treatment
setting?
Directional Hypotheses:
b) The initial level of motivation for treatment would be negatively correlated
with OCD symptom severity at discharge. Namely, higher motivation at
admission would be correlated with lower symptom severity at discharge.
c) The initial level of motivation for treatment would predict treatment outcome
when controlling for the length of treatment, baseline levels of OCD
symptoms, and baseline levels of depressive symptoms.

Research Question Two (Q2). To what extent did initial level of intrinsic motivation
predict treatment outcome for patients receiving intensive cognitive-behavioral
therapy for obsessive-compulsive disorder in a residential treatment setting?
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Directional Hypotheses for Intrinsic Motivation:
a) The initial level of intrinsic motivation for treatment would be negatively
correlated with OCD symptom severity scores at discharge. Namely, higher
level of intrinsic motivation at admission would be correlated with lower
symptom severity at discharge.
b) The initial level of intrinsic motivation would predict treatment outcome when
controlling for length of treatment, baseline level of OCD symptoms, and
baseline level of depressive symptoms.

Research Question Three (Q3). To what extent did initial level of extrinsic motivation
predict treatment outcome for patients receiving intensive cognitive-behavioral
therapy for obsessive-compulsive disorder in a residential treatment setting?
Given that this was the first study of the relationship between extrinsic motivation
and OCD treatment outcome, exploratory analyses were conducted to determine the
extent to which extrinsic motivation level predicted treatment outcome.
Exploratory Question regarding Extrinsic Motivation
a) To what extent is treatment outcome correlated with level of extrinsic
motivation for OCD treatment?
b) To what extent was treatment outcome predicted by initial level of
extrinsic motivation for treatment when controlling for length of
treatment, baseline level of OCD symptoms, and baseline level of
depressive symptoms?
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Research Question Four (Q4). To what extent did level of motivation predict
treatment dropout for patients receiving intensive cognitive-behavioral treatment
for obsessive-compulsive disorder in a residential treatment setting?
Exploratory Questions:
a) To what extent was treatment dropout predicted by initial level of overall
motivation for OCD treatment?
b) To what extent was treatment dropout predicted by initial level of intrinsic
motivation for OCD treatment?
c) To what extent was treatment dropout predicted by initial level of extrinsic
motivation?
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CHAPTER 2
METHOD

Participants
Participants in this study were 142 individuals admitted to the
McLean/Massachusetts General Hospital OCD Institute (OCDI) between January, 2001
and January, 2004. Each participant was assigned a diagnosis of obsessive-compulsive
disorder through a process consisting of assessments conducted by a psychiatrist and a
behavior therapist with expertise in OCD as well as by the administration of several
standardized assessment instruments.
Criteria for admission to the OCDI included the presence of OCD with associated
severe life impairment and inadequate response to prior OCD treatment. Appropriateness
for admission was determined by the Intake Coordinator via information gathered
through various sources including pre-treatment scores on the Y-BOCS and collateral
information from referring clinicians and family members. This study will use intent-totreat methodology in which all patients accepted to the program between January, 2001
and January 2004 who completed admission measures were included, regardless of
whether they completed or complied with the program.

Setting
The Massachusetts General Hospital/McLean OCDI is an intensive residential
treatment program (IRT) for individuals suffering from treatment-refractory OCD. It is
the oldest of three IRT centers in the United States. Researchers have promoted IRT as an
innovative and promising treatment approach for individuals with severe and debilitating
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OCD symptoms who have not responded to traditional outpatient CBT treatments
(Stewart, Egan Stack, Farrell, Pauls, Jenike, 2005; Willis, Rosqvist, Egan, Baney, Manzo,
1998). IRT has been shown to be an effective treatment in North American samples
(Stewart et al., 2005) and European samples (Drummond, 1993; Thornicroft, Colson &
Marks, 1991). More than a decade ago emergent research in Britain supported IRT as a
viable alternative to neurosurgery and general inpatient psychiatric admission for
treatment refractory OCD (Drummond, 1993; Thornicroft et al., 1991). Since that time,
several IRT programs similar to the OCDI at McLean Hospital, have been developed in
the United States to treat severe treatment-resistant OCD (see Osgood-Hynes, Riemann,
Björgvinsson, 2003).
The OCDI provides specialized intensive behavioral, medication and milieu OCD
treatment (Stewart et al., 2005). Treatment is provided at both the residential and “day
patient” levels of care, with residents receiving around-the-clock interventions beginning
with activities of daily living upon awakening in the morning (e.g., showering, grooming,
and eating) to assistance with bedtime routines. Treatment is administered by a
multidisciplinary team of psychiatrists, behavior therapists, social workers, nurses, and
counselors within a highly structured program that enables close monitoring of treatment
adherence. Participants in the OCDI treatment program receive two to four hours of
intensive CBT daily, and psychopharmacology assessments weekly by OCD expert
psychiatrists to monitor medication efficacy and side effects. Typical medications
utilized at the OCDI include selective serotonin reuptake inhibitors (SSRIs) such as
venlafaxine (Effexor) and clomipramine (Anafranil). Furthermore, all patients have
regular meetings with a social worker and attend weekly group psychotherapy sessions
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focusing on a variety of topics including symptom specific groups (e.g., scrupulosity,
violent obsessions, etc.) or more general groups focusing on overall wellness. The focus
of several of these groups is on problem-solving, life-rehabilitation goals, OCD-related
goals, and peer support (Osgood-Hynes, Riemann, & Bjorgvinsson, 2003).
The program’s main treatment focus is on daily intensive exposure and response
prevention (ERP) sessions combined with medication therapy. Behavior therapy is
conducted both in-vivo at the OCDI and in office sessions with behavior therapists. In
vivo therapy sessions occur outside the context of the therapist’s office and can occur in a
variety of settings where the client is frequently triggered (e.g., trips to the grocery store,
making food for lunch, driving one’s car). For the most part, behavior therapy consists of
ERP augmented with cognitive therapy. Patients follow individualized exposure and
response prevention plans during a 2-hour block of time set aside in the morning for ERP
tasks (10 a.m. to 12 p.m.) and then again during a 2-hour afternoon ERP session (2 p.m.
to 4 p.m.). Moreover, many treatment plans include the augmentation of behavioral
coaching for morning and nighttime routines to assist patients in resisting rituals during
their activities of daily living.

Procedure
Participants in this study completed three measures at regularly scheduled
intervals during the course of their treatment at the OCDI. The measures assessed a
variety of domains including OCD symptom severity, motivation for OCD treatment, and
depressive symptom severity. These measures included: (1) a demographic questionnaire
including past medical history administered upon intake, (2) Yale-Brown Obsessive
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Compulsive Scale, (3) Treatment Self-Regulation Questionnaire, and the (4) Beck
Depression Inventory. These measures were administered as a means of monitoring the
patient’s progress during his or her stay at the OCDI. Patients were initially administered
these measures at admission to the program to provide a baseline measurement. They
were then administered the measures after two weeks and then monthly thereafter until
the point of discharge from the OCDI. For patients with premature discharges (prior to
two weeks), the final completed assessment served as the discharge measure for this
study.

Measures
Demographics (Appendix A & B). Information on the each participant’s age,
gender, and ethnicity was collected from archived medical records. Furthermore,
information was gathered on the participant’s OCD treatment history including past
treatments (i.e., medication, CBT, etc.) and level of care (i.e., outpatient and/or inpatient
psychiatric admissions).
Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Appendix C). The
participant’s response to treatment was measured using the Yale-Brown Obsessive
Compulsive Scale (Y-BOCS; Goodman et al., 1989a). The Y-BOCS, which assesses the
overall severity of OCD symptoms, is considered the gold standard of tools in the
assessment of OCD symptom severity. The Y-BOCS is administered and scored by a
trained interviewer. Psychometric studies indicate that the Y-BOCS exhibits high
convergent validity with the NIMH Obsessive-Compulsive Scale (r = 0.67) and is
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sensitive to change and improvement in OCD, relative to the Clinical Global
Impressions-Obsessive Compulsive Scale (r = 0.89) (Goodman et al., 1989a, b).
The Y-BOCS assesses five dimensions independently for obsessions (Items 1-5)
and compulsions (Items 6-10): (a) time spent on these behaviors, (b) interference that
these behaviors cause, (c) distress that the individual experiences, (d) degree of resistance
to the symptoms, and (e) amount of control that the individual has over these behaviors.
Each item is rated from 0 (lowest severity) to 4 (highest severity), and includes item
probes and anchor points to guide the rater. The total Y-BOCS score is the sum of Items
1 to 10 (range = 0 to 40). The Y-BOCS is typically utilized as one of several assessment
tools to aid in the diagnostic process and as a measure of symptom severity. The
developers of the Y-BOCS scale provide the following recommended descriptors for
assessing symptom severity: score of 1-7 is considered sub-clinical; score of 8-15 is
considered mild; score of 16-23 is considered moderate; score of 24-31 is considered
severe; score of 32-40 is considered extreme (Goodman et al., 1989). The Y-BOCS also
contains a symptom checklist which measures the current and past experience of 15
categories of obsessions and compulsions.
Treatment Self-Regulation Questionnaire (TSRQ; Appendix D). Individual
differences in motivational orientation (intrinsic and extrinsic motivation for treatment)
was assessed using the Treatment Self-Regulation Questionnaire (Williams et al., 1996).
The TSRQ measures the extent to which individuals engage in specific health behaviors
of their own volition because such behaviors hold personal importance for them, rather
than engaging in health behaviors as a response to external pressures. In past research, the
TSRQ has been modified to address specific health behaviors such as diet, exercise,
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smoking cessation and psychotherapy. The TSRQ has demonstrated strong construct
validity and reliability in psychometric studies (Levesque, Williams, Elliot, Pickering,
Bodenhamer & Finley, 2006), and research supports its usefulness as a tool to assess
motivation for treatments for a variety of health-related issues and psychological
problems (Kennedy, Goggin & Nollen, 2004; Williams et al., 2002; 2004).
Scale items were modified for the purpose of this study to address adherence to
OCD treatment specifically. Using a 7-point Likert-type scale participants rated their
agreement with 13 items describing the reasons that they continue to participate in
treatment for their OCD symptoms (1 = not at all true; 7 = very true). Intrinsic
motivation was determined by mean ratings for the five items on the Autonomous
Responses subscale (e.g., “Because I feel like it is the best way to help myself.”).
Extrinsic motivation was determined by mean ratings for the eight items on the
Controlled Responses subscale (e.g., “Because others would have been angry at me if I
didn’t.”).
Beck Depression Inventory (BDI; Appendix E). The BDI (Beck et al., 1961) is a
21-item self-report instrument that assesses the presence and severity of symptoms of
depression. The BDI has been used for over 45 years in the assessment of depression and
has been found consistently to be reliable and valid in a variety of populations.
Moreover, psychometric studies have indicated that the BDI exhibits strong psychometric
properties with well-established validity and reliability (Burt & Ishak, 2002). The BDI is
correlated with clinician ratings of depression with correlations ranging from .62 to .66
(Beck, Steer, & Garbin, 1988). Groth-Marnat (2003) reported moderate correlations
between the revised BDI and other scales measuring depression such as the Hamilton
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Psychiatric Rating Scale for Depression (.73) and the Zung Self Reported Depression
Scale (.76) and the MMPI Depression Scale (.76). Furthermore, The BDI demonstrates
high internal consistency, with alpha coefficients of .86 and .81 for psychiatric and nonpsychiatric populations, respectively (Beck, Steer, & Garbin, 1988). The BDI also
demonstrates significant discriminant validity and is able to discriminate psychiatric
patients from non-psychiatric patients (Beck et al., 1988; Groth-Marnat, 2003)
Each item of the BDI is rated on a four-point scale from 0 to 3. The total BDI
score is the sum of items 1 to 21 (range = 0 – 63). The Center for Cognitive Therapy has
provided the following guidelines for BDI cut-off scores with patients diagnosed as
having an affective disorder: none or minimal depression is < 10, mild to moderate
depression is 10–18, moderate to severe depression is 19–29, and severe depression is
30–36 (Beck et al., 1988).

Data Analyses
Data were coded from multiple time points for each participant including
assessments conducted at: (1) the initial intake, (2) two-week point, (3) monthly points,
and (4) discharge date. For those with premature discharges (prior to 2 weeks), the last
completed assessment was used in the analysis as the discharge measure (via a lastobservation-carried-forward approach. The primary outcome measure for this study was
the individual’s Y-BOCS score at discharge. Treatment response was defined by a YBOCS score reduction of at least 25%, a measure of clinically meaningful symptom
alleviation (Goodman et al., 1993).
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Descriptive analyses were conducted for the entire sample to determine the
means, distribution, and variability of the data. Multiple regression analyses were
conducted to answer the first three research questions to examine the relationship
between initial level of overall motivation, initial level of intrinsic motivation and initial
level of extrinsic motivation on OCD treatment outcome. The regression analyses were
conducted using the techniques of Aiken and West (1991), who recommend centering
outcome variables and avoiding artifacts of regression. In each of the regression
analyses, length of treatment, initial OCD symptom severity, and initial depressive
symptom severity were entered in as control variables. As discussed in the introductory
section of this paper, previous research has suggested that these variables contribute to
treatment outcomes for individuals receiving treatment for OCD. Therefore, these
control variables were included in the construction of the model in order to accurately
identify the unique predictive value of the primary variables of interest (i.e., overall,
intrinsic, and extrinsic motivation).
Data Analysis Strategy for Q1. Question 1 examined the relationship between
initial level of overall motivation for treatment and OCD symptom severity at the
conclusion of treatment. To answer this question, a hierarchical multiple regression
analysis was performed. The association between level of overall motivation and OCD
symptom severity at treatment discharge was tested, controlling for length of treatment,
severity of OCD symptoms upon admission to the treatment program, and severity of
depressive symptoms upon admission.
Data Analysis Strategy for Q2. Question 2 examined the relationship between
initial level of intrinsic motivation for treatment and OCD symptom severity at the
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conclusion of treatment. To answer this question, a hierarchical multiple regression
analysis was performed. The association between level of intrinsic motivation at
admission and OCD symptom severity at treatment discharge was tested, controlling for
length of treatment, severity of OCD symptoms upon admission to the treatment
program, and severity of depressive symptoms upon admission.
Data Analysis Strategy for Q3. Question 3 examined the relationship between
initial level of extrinsic motivation for treatment and OCD symptom severity at the
conclusion of treatment. To answer this question, a multiple regression analysis was
performed. The association between level of extrinsic motivation at admission and OCD
symptom severity at treatment discharge was tested, controlling for length of treatment,
severity of OCD symptoms upon admission to the treatment program, and severity of
depressive symptoms upon admission.
Data Analysis Strategy for Q4. Question 4 examined the extent to which level of
motivation for OCD treatment as measured by the TSRQ predicted treatment dropout.
Given the relatively small number of treatment dropouts (i.e., 5 of 142), descriptive data
are presented in lieu of statistical analyses involving prediction (i.e., logistic regression).
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CHAPTER 3
RESULTS AND DISCUSSION
Preliminary Steps
Several preliminary steps were conducted before beginning the major phase of
data analysis. Data entry was verified for accuracy by checking each response against the
hard copies of questionnaires; miscoded entries were corrected. Each scale was then
examined for missing data. Next, demographic information (see Table 1 and 2),
descriptive statistics (see Table 3), and bivariate correlations of study variables (Table 4)
were examined. This information is described in detail in the subsequent subsections.
Finally, specific steps were taken prior to running regression analyses, and subsequently
on the residuals, to check that all necessary assumptions were met to ensure that the
results of the regression analyses would be generalizable beyond this particular sample.
Analyses of these assumptions (i.e., normality, linearity, homoscedasticity, independence
of the residuals, lack of extreme outliers, and multicollinearity) revealed few violations,
and none were extreme. Furthermore, analyses indicated that the residuals were normally
distributed; thus, no transformations of the data were necessary for the regression
analyses. Statistical analyses were conducted using the Statistical Package for the Social
Sciences (SPSS 14.0). For all statistical analyses presented and discussed in this chapter,
a two-tailed probability level of p<.05 was used as the criterion for statistical
significance.
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Demographic and Descriptive Statistics
Demographic information for this sample is presented in Table 1. Participants in
this study had a mean age of 34.23 years (SD 12.3; range 16 – 68), and the gender
representation was 58.5% male. The ethnic makeup of this sample was 85.2% White (N
= 121), 1.3% African American/Black (N = 2), 2.1% Hispanic/Latino (N = 3), 2.1%
Asian American (N = 3), and 2.1 % Native American (N = 3). The majority of this
sample had completed at least a high school education with only 6.3 % of the sample
reporting that they had not completed high school. Approximately 28% (N = 39) of the
sample reported that they had completed a four-year degree and were college graduates,
while approximately 6% (N = 9) had completed an advanced degree (master’s degree,
doctoral degree, etc.). A substantial portion of this sample (36.6%) reported that they
were currently unemployed at the time of admission. Furthermore, only 19% (N = 17) of
the participants reported that they were married at the time of admission. This
demographic is consistent with other studies involving individuals with severe OCD
symptoms.
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Table 1
Patients’ Demographic Characteristics: Gender, Age, Ethnicity, Education, Employment
and Marital Status
N
Gender
male
female
Age
0 – 18
19 – 25
26 – 40
41 – 55
56 – 65
65 – 80
not reported

%
83
59

58.5
41.5

5
33
58
28
5
3
10

3.5
23.3
40.9
19.7
3.5
2.1
7.0

121
3
3
3
2
10

85.2
2.1
2.1
2.1
1.3
7.2

Education Level
Did not complete high school
Completed 2-year trade school
High school graduate
Completed 4-year degree (college, etc.)
Completed graduate degree (M.A., Ph.D.)
Not reported

9
7
46
39
9
32

6.3
4.9
32.4
27.6
6.3
22.5

Employment Status
Employed
Unemployed
Not reported

57
52
33

40.1
36.6
23.3

Marital Status
Single (never married)
Married
Divorced
Partnered
Separated
Not reported

75
27
10
4
3
23

52.8
19.0
7.0
2.8
2.1
16.3

Ethnicity
Caucasian/White
Hispanic/Latino
Native American
Asian American
African American/Black
Not reported
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Information regarding the severity and psychiatric history of this sample is
presented in Table 2. On average, individuals reported severe OCD symptoms (mean
score on the Y-BOCS at admission = 26.6; SD = 6.36; range = 8 – 40), and moderate to
severe depression (mean score on the BDI at admission = 21.27; SD = 10.99; range = 8 –
40). The mean age of OCD onset for this sample was 15.9 (SD = 9.84; range = 3 – 65).
The OCD treatment history in this sample was extensive, with 98.6% having received
some form of OCD treatment in the past. The number of past psychiatric admissions
ranged between 0 and 12 (mean = 1.61), with 57.7% having had at least one past
inpatient psychiatric admission. Thus, this OCD sample was severely impaired despite
an extensive treatment history.

Table 2
Demographic Data Related to Mental Illness
Demographic
Reported age of OCD onset

M
15.96

SD
9.84

Range
3 – 65

Age at admission to OCDI

34.23

12.3

16 - 68

1.61

2.31

0 - 12

Y-BOCS score at admission

26.66

6.36

8 – 40

BDI score at admission

21.27

10.99

0 − 52

Number of past psychiatric admissions

Table 3 presents descriptive data for the specific predictor and outcome variables
examined in this study (i.e., Y-BOCS at admission, Y-BOCS at discharge, total TSRQ
score at admission, total score on the intrinsic motivation subscale, total score on the
extrinsic motivation subscale, BDI score at admission, and length of treatment in days).
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Mean Y-BOCS scores were 26.66 (SD = 6.36) at admission to the program and 17.12 (SD
= 6.93) at discharge, reflecting a substantial mean Y-BOCS decrease of 9.51 points or
35.78%. This improvement in symptom scores represents a clinically significant OCD
treatment response (as defined by Jacobsen & Truax, 1991). Mean depression scores, as
measured by the BDI, improved substantially from depressed (M = 21.27; SD = 10.99) to
a subthreshold level (M = 13.02; SD =12.05), indicating a clinically significant decrease
on the BDI scale of 8.25 points or 38.79%. On average, the level of intrinsic motivation
reported by the patients in this study (M = 3.73; SD = 1.32) were significantly higher
than the level of extrinsic motivation (M = 2.64; SD = .90). The average length of
treatment for patients in this sample was 52.92 days (SD = 31.01).
Table 3
Descriptive Statistics for Predictor and Outcome Variables (N = 142)
Variables

Range
M

SD

Absolu
te
mean
decreas
e

%
decrease
in
symptom
s

Y-BOCS score
at admission
at discharge

26.66
17.12

6.36 8 – 40
6.93 1 - 33

9.51*

35.78*

BDI score
at admission
at discharge

21.27
13.02

10.99 0 − 52
12.05 0 - 57

8.25*

38.79*

Total TSRQ score at admission
Mean intrinsic motivation
Mean extrinsic motivation

41.33
3.73
2.64

8.57
1.32
.90

1152
Note. * Clinically significant decrease in symptoms as defined by Jacobsen and Truax,
1991.
Length of treatment in days

52.92

39

31.01

21 –
63
1−5
1−5

Bivariate Correlations for Predictors and Outcome Variable
Preliminary analysis examined the relationship between predictors and outcome
variables. Bivariate correlations for the study variables are presented in Table 4. Results
in Table 4 indicate significant positive correlations between OCD treatment outcome
(i.e., Y-BOCS score at discharge) and several predictor variables. Consistent with
previous research conducted on OCD treatment outcome (Franklin et al., 2000; Keeley,
Storch, Merlo, & Geffken, 2008), higher OCD symptom severity at admission, as
measured by the Y-BOCS, was positive correlated with higher OCD symptom severity at
discharge (r = .412, p < .001). Furthermore, higher depressive symptom severity at
admission, as measured by the BDI, was positively correlated with higher OCD symptom
severity at discharge (r = .324, p < .001). Results also indicate that initial level of overall
motivation and level of extrinsic motivation, as measured by the TSRQ, were positively
correlated with OCD symptom severity at discharge. This is to say, that a higher level
overall motivation scores was significantly related to higher OCD symptom severity
scores at discharge (r = .239, p < .01). Moreover, higher scores on the extrinsic
motivation subscale were significantly related to higher OCD symptom severity scores at
discharge (r = .275, p < .001). No significant correlation was found between OCD
treatment outcome and level of intrinsic motivation (r = .043, p = .613) or length of
treatment (r = .17, p = .100).
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Table 4
Correlations for Predictor and Outcome Variables (N = 142)
Variables

1

1. Y-BOCS at
admission
2. Y-BOCS at
discharge
3. TSRQ score

−

2

3

4

6

7

.069

.296*** .514*** .139t

.239**

.043

.275*** .324*** .139t

−

.394*** .814*** .203*

.162t

.125

.013

.053

−

.130

.184*

−

.061

.412*** .288***
−

5

4. Intrinsic
motivation
5. Extrinsic
motivation
6. BDI at admission

−

7. Length of
Treatment
Note. *p < .05. **p < .01. ***p < .001. tp < .10

−

Research Question One (Q1): Did level of overall motivation predict OCD treatment
outcome?
This research question assessed the extent to which level of overall motivation for
treatment predicted treatment outcome for patients receiving intensive cognitivebehavioral therapy for OCD. To examine this question, a hierarchical linear regression
was conducted. The dependent variable was a measure of OCD symptom severity at the
conclusion of treatment (Y-BOCS). Results of this hierarchical regression analysis are
presented in Table 5.
In Step 1, baseline OCD symptom severity (i.e., Y-BOCS at admission) and length
of treatment were entered as covariates. Past research has identified baseline symptom
severity and length of treatment as significant predictors of treatment outcome (Franklin
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et al., 2000; Keeley, Storch, Merlo, & Geffken, 2008); therefore, these variables were
included in the model as control variables, allowing a test of the effect of the predictor of
interest (i.e., level of overall motivation) over and above those predictors identified in
previous research. In support of previous research, results of Step 1 of the model
indicated that baseline OCD symptom level significantly contributed to the prediction of
treatment outcome in this sample (β = .298, p<.01), with higher OCD symptom severity
at admission associated with higher OCD symptom severity at discharge. However,
contrary to previous research findings, length of treatment was not a significant predictor
of treatment outcome in this sample (β = .068, p = .366). Results of Step 1 of the model
indicated that baseline OCD symptom severity and length of treatment accounted for
approximately 17.7% of the variation in OCD treatment outcome (R2 = .177, p < .001).
In Step 2, baseline depressive symptom severity (i.e., BDI at admission) was entered as a
predictor. The decision to include depression as a predictor in the overall model was
based on previous research demonstrating a relationship between higher rates of
depression and poorer treatment outcomes (Abramowitz, 2004; Abramowitz et al., 2000;
Franklin et al., 2000; Steketee, Chambless, & Tran, 2000). Depressive symptom severity
was entered independently in the model to examine its effect over and above variables
that have been identified as predictors in previous research (i.e., baseline OCD symptom
severity and length of treatment). Furthermore, depressive symptom severity was entered
prior to the primary variable of interest (i.e., level of overall motivation) in order to
examine the unique impact of depressive symptoms on treatment outcome. In Step 2, the
addition of depressive symptom severity to the model did not significantly improve
prediction of treatment outcome (β = .140, p = .088). This lack of a significant
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relationship is contrary to past research which identified severity of depressive symptoms
as a predictor of OCD treatment outcome.
Finally, in Step 3 level of overall motivation for treatment, as measured by the
TSRQ score at admission, was entered into the model to answer Research Question 1.
Results failed to indicate that initial level of overall motivation for treatment was a
significant predictor of OCD symptom severity at the conclusion of treatment (β = .118 p
= .161) when controlling for length of treatment, baseline severity of OCD symptoms
upon admission, and baseline severity of depressive symptoms. Therefore, the data do
not support the hypothesis that higher level of overall motivation for treatment at
admission would be significantly correlated with lower symptom severity at discharge.
Given that it is possible that motivation may have a differing effect contingent
upon level of symptom severity, an additional step was taken to examine whether the
effect of level of overall motivation was dependent on the level of severity of symptoms
at admission. In other words: Would motivation have the same impact on treatment
outcome for an individual with high initial symptom severity at the outset of therapy as it
would for an individual with low initial symptom severity? To this end, interaction terms
between level of overall motivation and initial depressive severity, and level of overall
motivation and initial OCD severity, were added to the model in subsequent steps to
examine the possibility of interaction effects and their predictive contribution to the
variance of this model. Neither of the interactions was significant, and their inclusion did
not significantly improve the explanatory power of the model.
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Discussion and Interpretation of Results for Question One:
Results of this study do not support the hypothesis that higher level of overall
motivation for treatment at admission would be predictive of OCD treatment response.
These results are contrary to previous findings in health-related domains where a
considerable amount of research has demonstrated that level of overall motivation at the
outset of treatment is a significant predictor of treatment response (Feld et al., 2001;
Geller, 2002; Touyz et al., 2003; Vansteenkiste et al., 2005; Williams et al., 2006). The
results of the present study are surprising given the amount of emphasis in the literature
placed on the role of motivation in the treatment of anxiety disorders including OCD. As
noted in the introduction, several theorists and researchers have asserted that a level of
motivation is an essential component in the OCD treatment process (e.g., Arkowitz,
Westra, Miller, & Rollnick, 2008; Foa, 2000), leading some clinicians to advocate for
assessing level of overall motivation at the outset of treatment. Despite this assumption,
some recent studies, including the present study, have failed to demonstrate that overall
level of motivation at admission is a predictor of OCD treatment response (Pinto, Pinto,
Neziroglu, & Yaryura-Tobias, 2007; Vogel, Hansen, Stiles, & Gotestam, 2006).
As suggested by the present results, level of overall motivation at admission may
not predict OCD treatment outcome. However, these findings should be interpreted with
caution when drawing conclusions about the role of motivation in OCD treatment
response. It is important to note that the present study investigated level of overall
motivation at the outset of treatment and did not examine motivation during the course of
treatment. The decision to measure level of motivation at the outset of treatment was
based on previous research conducted in health-related domains (i.e., diabetes, smoking
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cessation, weight control, etc.) where level of motivation was assessed at admission in
most studies. The findings of the present investigation are consistent with a study
conducted by Vogel and colleagues (2006), which explored predictors of OCD treatment
response including treatment motivation, treatment expectancy, and treatment alliance.
In that study, treatment expectancy and high level of motivation to change were not
significantly related to post-treatment outcome; however, a positive therapeutic alliance
(measured at mid-treatment) was significantly predictive of post-treatment Y-BOCS
score. Similarly, in a study conducted by Pinto and colleagues (2007), motivation scores
at admission were not predictive of treatment response for individuals receiving an openlabel 10-week trial of fluvoxamine. Of note, as with the present study design, both of the
abovementioned studies assessed overall level of motivation at the outset of treatment,
and no measurement of motivation was made during the course of treatment.
It may be the case that motivation plays a different role in the OCD treatment
process than it does in interventions for health-related problems. That is to say, although
level of motivation at admission to a program may be a significant predictor of response
for individuals entering a smoking cessation or weight loss program, the role of
motivation in OCD treatment may be more complex. Indeed, many of the individuals in
the present study reported a high level of overall motivation at the outset of treatment.
However, given the highly aversive and demanding nature of this treatment, level of
motivation may have fluctuated substantially over the course of treatment depending on
the behavioral tasks required. For example, some patients may have begun therapy with
the best of intentions for changing their behavior; however, when faced with particularly
difficult exposure tasks they may have experienced a sharp increase in ambivalence
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accompanied by a lowering of overall level of motivation. Therefore, it may be the case
that level of overall motivation at the outset of treatment does not predict OCD treatment
outcome, but rather the ability to maintain a high level of motivation over the course of
treatment is predictive of outcome. More research is needed to investigate the fluctuating
course of motivation during the OCD treatment process and its effect on outcome.
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Table 5
Summary of Hierarchical Multiple Regression Analysis for Level of Overall Motivation for Treatment and Control Variables
Predicting OCD Treatment Outcome (N = 142)
Step 1
Variable

B

Y-BOCS at admission

.437

.085

Length of Treatment

.019

.017

Step 2
β

SE B

.401***
.083

BDI score at admission

B

Step 3
β

SE B

.351

.098

.019
.097

B

β

SE B

.322

.100

.296***

.017

.322**
*
.085

.016

.017

.070

.056

.153t

.091

.056

.145

.092

.065

.113

TSRQ score at
admission
TSRQ x BDI
TSRQ x YBOCS
R2

.177***

.194***

Change in R2

.017

.206**
1.988

Note: Y-BOCS at admission, BDI score at admission and overall motivation were centered at their means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10
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Table 5
Continued.
Step 4
Variable

B

Y-BOCS at admission

.327

.100

Length of Treatment

.015

BDI score at admission
TSRQ score at
admission
TSRQ x BDI

Step 5
β

SE B

SE B

β

.324

.101

.017

.301**
*
.068

.015

.017

.298**
*
.068

.088

.057

.140

.089

.057

.140

.093

.065

.115

.095

.066

.118

-.003

.006

-.042

-.002

.006

-.033

-.003

.010

-.023

TSRQ x YBOCS
R2

B

.207***

.208***

Change in R2

.000
.002
Note: Y-BOCS at admission, BDI score at admission and overall motivation were
centered at means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10

Research Question Two (Q2): Did level of intrinsic motivation predict OCD treatment
outcome?
This research question assessed the extent to which level of intrinsic motivation
for treatment predicted treatment outcome for patients receiving intensive cognitivebehavioral therapy for OCD. Despite the lack of evidence supporting level of overall
motivation predicting treatment outcome in Research Question 1, some research findings
indicate that the specific quality or type of motivation (i.e., intrinsic or extrinsic
motivation) may have distinct predictive power (Harter & Jackson, 1992; Pelletier,
Tuson, Haddad, 1997). To examine this question, a hierarchical linear regression was
performed. The dependent variable was a measure of OCD symptom severity at the
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conclusion of treatment (Y-BOCS). Results of this hierarchical regression analysis are
presented in Table 6.
Similar to the first analysis, in Step 1 baseline OCD symptom severity (i.e., YBOCS at admission) and length of treatment were entered as covariates. The first two
steps were identical to those run in the previous model. These variables were included in
the model as control variables, allowing for a test of the effect of the predictor of interest
(i.e., level of intrinsic motivation) over and above those predictors identified in previous
research. In support of previous research and consistent with our finding from Question
1, results of Step 1 of the model indicated that baseline OCD symptom level significantly
contributed to the prediction of treatment outcome in this sample (β = .301, p<.01), with
higher OCD symptom severity at admission being associated with higher OCD symptom
severity at discharge. However, similar to the results of the analysis for Research
Question 1, and contrary to previous research findings, length of treatment was not a
significant predictor of treatment outcome in this sample (β = .098, p = .197).
In Step 2, baseline depressive symptom severity (i.e., BDI at admission) was
entered as a predictor. Depressive symptom severity was entered independently in the
model to examine its effect over and above variables that have been identified as
predictors in previous research (i.e., baseline OCD symptom severity and length of
treatment). Furthermore, depressive symptom severity was entered prior to the primary
variable of interest (i.e., level of intrinsic motivation) to examine the unique impact of
depressive symptoms on treatment outcome. In Step 2, the addition of depressive
symptom severity to the model did not significantly improve prediction of treatment
outcome (β = .105, p = .233). This lack of a significant relationship is contrary to past
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research which has identified severity of depressive symptoms as a significant predictor
of OCD treatment outcome. However, it is consistent with findings for Research
Question 1.
In Step 3, the variable of interest, level of intrinsic motivation, was entered into the model
to specifically address Research Question 2. Results failed to indicate that level of
intrinsic motivation for treatment was a significant predictor of OCD symptom severity at
the conclusion of treatment (β = .021 p = .788) when controlling for length of treatment,
baseline severity of OCD symptoms upon admission, and baseline severity of depressive
symptoms. Therefore, no evidence was found to support the hypothesis that a higher
level of intrinsic motivation for treatment at admission is a significant predictor of
treatment outcome.
Additionally, as with the analysis for Question 1, given that it is possible that
level of intrinsic motivation may have a differing effect contingent upon level of
symptom severity, steps were taken to examine whether the effect of intrinsic motivation
was dependent on the level of severity of symptoms at admission. To investigate this
question, interaction terms between level of intrinsic motivation and initial depressive
severity, and level of intrinsic motivation and initial OCD severity, were added to the
model in subsequent steps to examine the possibility of interaction effects and their
predictive contribution to the variance of this model. In Step 4 the interaction between
level of intrinsic motivation and depressive severity (i.e., Int X BDI) was entered as a
predictor. Results indicate that this interaction term was not a significant predictor of
treatment outcome, and did not significantly improve the explanatory power of the
model.
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Finally, in Step 5 the interaction between level of intrinsic motivation and OCD
symptom severity (i.e., Int X Y-BOCS) was entered as a final predictor. Interestingly,
results indicated that the interaction between level of intrinsic motivation and OCD
symptom severity at admission was a significant predictor of treatment outcome (β = .235, p <.01) in this model. Moreover, the inclusion of this interaction term significantly
improved the prediction model (Change in R2 = .044, p<.01). The sample multiple
correlation coefficient for this model was .51, indicating that the full regression model
accounted for approximately 26% of the total variance in OCD treatment outcome (R2 =
.261, p < .001).
Figure 1 illustrates how the effect of level of intrinsic motivation on treatment
outcome varies depending on initial OCD symptom severity (Y-BOCS score at
admission). As shown in Figure 1, the outcomes of patients with a low level of intrinsic
motivation differ according to their level of symptom severity at the outset of treatment.
Those patients having high initial OCD symptom severity and low level of intrinsic
motivation at the outset of treatment had poorer treatment outcomes (higher Y-BOCS
scores at discharge) than did fellow patients with high initial symptom severity who also
had a high level of intrinsic motivation. For individuals entering treatment with a high
level of severity of symptoms at treatment outset, a high level of intrinsic
motivation is related to better outcome.
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Table 6
Summary of Hierarchical Multiple Regression Analysis for Level of Intrinsic Motivation for Treatment and Control Variables
Predicting OCD Treatment Outcome (N = 142)
Step 1

Step 2

Variable

B

SE B

β

Y-BOCS at admission

.437

.085

Length of Treatment

.019

.017

.401**
*
.083

BDI score at
admission
Intrinsic motivation

B

SE B

.351

Step 3
β

.098

.019

.322**
*
.017 .085

.097

.056

.153t

B

β

SE B

.349

.098

.321***

.019

.017

.084

.097

.056

.154 t

.075

.403

.014

Int x BDI
Int x Y-BOCS
R2

.177***

.194***

Change in R2

.194***

.017t
.000
Note: Y-BOCS at admission, BDI score at admission and intrinsic motivation were centered at their means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10
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Table 6
Continued.
Step 4
β

B
.328

.095

.017

.314**
*
.069

.022

.017

.301**
*
.098

.083

.056

.131

.066

.055

.105

.107

.399

.021

-.104

.396

-.020

-.072

.036

-.153t

-.031

.038

-.066

-.156

.055

Variable

B

Y-BOCS at admission

.342

.097

Length of Treatment

.015

BDI score at
admission
Intrinsic motivation
Int x BDI

Step 5

SE B

Int x Y-BOCS
R2
Change in R2

β

SE B

.217***

.235**
.261***

.022t

.044**

Note: Y-BOCS at admission, BDI score at admission and intrinsic motivation were
centered at their means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10
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OCD Treatment Outcome (Y-BOCS)

Figure 1
Interaction Between Intrinsic Motivation and Initial
OCD Symptom Severity Predicting Treatment Outcome
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Discussion and Interpretation of Results for Question Two:
The second research question addressed the extent to which level of intrinsic
motivation for treatment predicted treatment outcome for patients receiving intensive
cognitive-behavioral therapy for OCD. Researchers have postulated that it is not only the
level of motivation that is important in treatment outcome, but also the specific quality or
motivational orientation (i.e., intrinsic or extrinsic motivation) that may have distinct
predictive power (Deci & Ryan, 2000; Harter & Jackson, 1992; Pelletier, Tuson, Haddad,
1997). In particular, in the realm of health-related research, intrinsic motivation for
engaging in treatment has been shown to lead to better outcome for a variety of problems
including diabetes (G.C. Williams, Freedman, & Deci, 1998), morbid obesity (Williams,
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Grow, Freedman, Ryan, & Deci, 1996), opiate addiction (Zeldman, Ryan, & Fiscella,
2004), alcohol dependence (Ryan, Plant, O’Mally, 1995), and cigarette smoking
(Williams, Gagne, Ryan, & Deci, 2001). More recently, Zuroff and colleagues (2007)
extended this research from the health-related domain to the treatment of mental illness.
Ninety-five depressed outpatients were randomly assigned to receive 16 sessions of
manualized interpersonal therapy, cognitive behavioral therapy, or pharmacotherapy with
clinical management. Self-report and interviewer-based measures of depression severity
were collected at pre-treatment and post-treatment. Level of intrinsic motivation,
therapeutic alliance, and perceived therapist autonomy support were assessed at session
three. Intrinsic motivation was the strongest predictor of remission and lower posttreatment depressive symptoms in all three brief treatments for depression. Based on this
research, the hypothesis was made that a higher level of intrinsic motivation for OCD
treatment at admission would be a significant predictor of treatment outcome when
controlling for the length of treatment, baseline levels of OCD symptoms, and baseline
levels of depressive symptoms.
Results of the present study are generally consistent with past research
highlighting the importance of intrinsic motivation as a predictor of treatment outcome.
However, the present findings indicate that the relationship between intrinsic motivation
and OCD treatment outcome may be more complex than seen in previous studies in the
health-related domains. Results of this study suggest that the relationship between level
of intrinsic motivation and OCD treatment outcome is dependent upon the level of
severity of OCD symptoms at the outset for treatment. More specifically, patients
entering treatment with high OCD symptom severity and a low level of intrinsic
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motivation had poorer treatment outcomes, whereas those patients with high symptom
severity who also reported a high level of intrinsic motivation had better treatment
outcomes. This finding supports past research investigating the specific mechanisms by
which intrinsic motivation promotes change. Studies in non-psychotherapy contexts
suggest that patients with higher levels of intrinsic motivation may adhere more closely
to the prescribed treatment, may carry out therapeutic procedures more carefully and
persistently, and may persevere in treatment even when it becomes difficult or
discouraging (Markland, Ryan, Tobin, & Rollnick, 2005).
Results of the present study suggest that level of intrinsic becomes increasingly
important when OCD symptoms are more severe and thus more likely to interfere with
most areas of daily functioning. The findings of this study are consistent with a recent
study conducted by Nakagami and colleagues (2008) which examined the nature of the
relationship between intrinsic motivation and measures of neurocognition and
psychosocial functioning for individuals diagnosed with schizophrenia. Evidence from
Nakagami’s study suggests that intrinsic motivation is a significant factor for
understanding psychosocial functioning and may be critical to strategies for helping
patients with schizophrenia attain improved levels of functioning.
Interestingly, results of the present study indicate that intrinsic motivation may
play a different role for those individuals with lower symptom severity when compared to
those with higher symptom severity. For individuals with lower symptom severity at the
beginning of treatment, a higher level of intrinsic motivation may lead to slightly worse
treatment outcomes in an intensive setting. Although this finding may seem
counterintuitive at first glance, one explanation for this finding may relate to the type of
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treatment administered in this study. Patients in this study participated in a highly
intensive, structured, and all-encompassing form of treatment in which they were
continuously challenged to confront their symptoms by staff members throughout the
day. The treatment was designed to address patients’ symptoms in all phases of their
day-to-day lives. It is possible that for those individuals entering treatment with lower
symptom severity and a higher level of intrinsic motivation, this type of setting may
actually have been less beneficial and less appropriate for their treatment needs.
The findings of the present study lend support to the importance of matching
treatment interventions to both the symptom severity of the patient and to his or her level
of intrinsic motivation. In other words, patients with a higher severity of OCD symptoms
who are intrinsically motivated may benefit from more intensive and structured treatment
settings (e.g., the OCDI). Alternatively, highly intrinsically motivated individuals with
lower symptom severity may benefit more from treatments that capitalize on their
existing sense of autonomy (e.g., weekly outpatient treatment) and better match their
level of treatment needs. This finding is also consistent with the literature associated
with Self-Determination Theory (Deci & Ryan, 1995; 2002). According to Deci and
Ryan (1995), there are three basic human needs which motivate individuals to change or
initiate a behavior. One of the needs that Deci and Ryan describe as being most
important is the need for autonomy, or the need to experience one’s actions as
autonomous choices and without external influence. Self Determination Theory (Deci &
Ryan, 2000) posits that those with a higher level of intrinsic motivation experience their
choices as more autonomous. It may be the case that the intensive treatment program
offered at the OCDI is not well designed for individuals with lower symptom severity and
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a higher level of intrinsic motivation. For these individuals, higher intrinsic motivation at
admission may be indicative of a more intact and healthy sense of autonomy. Therefore,
a highly intensive setting with constant behavioral interventions may not be appropriate,
and may take away from one’s sense of autonomy.

Research Question Three (Q3): Did level of extrinsic motivation predict OCD treatment
outcome?
This research question assessed the extent to which level of extrinsic motivation
for treatment predicted treatment outcome for patients receiving intensive cognitivebehavioral therapy for OCD. To examine this question, a hierarchical linear regression
was performed. The dependent variable was a measure of OCD symptom severity at the
conclusion of treatment (Y-BOCS). Results of this hierarchical regression analysis are
presented in Table 7.
Similar to previous analyses, in Step 1 baseline OCD symptom severity (i.e., YBOCS at admission) and length of treatment were entered as covariates. These variables
were included in the model as control variables, allowing for a test of the effect of the
predictor of interest (i.e., level of extrinsic motivation) over and above those predictors
identified in previous research. In support of previous research and consistent with
findings from Research Questions 1 and 2, results of Step 1 of the model indicated that
baseline OCD symptom significantly contributed to the prediction of treatment outcome
in this sample (β = .401, p<.001), with higher OCD symptom severity at admission being
associated with higher OCD symptom severity at discharge. Moreover, similar to the
results of the analysis on Research Questions 1 and 2, length of treatment was not a
significant predictor of treatment outcome in this sample (β = .083, p = .288). Results of
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Step 1 of the model indicated that baseline OCD symptom severity and length of
treatment accounted for approximately 17.7% of the variation in OCD treatment outcome
(R2 = .177, p < .001).
In Step 2, baseline depressive symptom severity (i.e., BDI at admission) was
entered as a predictor. Depressive symptom severity was entered independently in the
model to examine its effect over and above variables that have been identified as
predictors in previous research (i.e., baseline OCD symptom severity and length of
treatment). Depressive symptom severity was entered prior to the primary variable of
interest (i.e., level of extrinsic motivation) to examine the specific impact of depressive
symptoms on treatment outcome. In Step 2, the addition of depressive symptom severity
to the model did not significantly improve prediction of treatment outcome (β = .153, p =
.088; Change in R2 = .017, p = .088).
In Step 3, the variable of interest, level of extrinsic motivation, was entered into
the model to specifically address Research Question 3. Interestingly, results indicate that
level of extrinsic motivation was a significant predictor of OCD treatment outcome (β =
.162, p < .05), with a higher level of extrinsic motivation associated with higher Y-BOCS
scores (i.e., more OCD symptoms) at the conclusion of treatment. Moreover, the
inclusion of extrinsic motivation significantly improved the prediction model (Change in
R2 = .023, p < .05). Results of Step 3 of the model indicated that baseline OCD symptom
severity, length of treatment, depressive severity, and level of extrinsic motivation
accounted for approximately 21.8% of the variation in OCD treatment outcome (R2 =
.218, p < .001). Level of extrinsic motivation was a significant predictor of outcome
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when controlling for length of treatment, baseline levels of OCD symptoms, and baseline
depressive symptoms.
Additionally, as with the previous analyses for Questions 1 and 2, given that it is
possible that level of extrinsic motivation may have had a differing effect contingent
upon level of symptom severity, steps were taken to examine whether the effect of level
of extrinsic motivation was dependent on the level of symptom severity at admission. To
investigate this question, interaction terms between level of extrinsic motivation and
initial depressive severity, and level of extrinsic and initial OCD severity, were added to
the model in subsequent steps to examine the possibility of interaction effects and their
predictive contribution to the variance of this model. In Step 4 the interaction between
level of extrinsic motivation and depressive severity (i.e., Ext X BDI) was entered as a
predictor. Results indicate that this interaction term did not significantly improve the
explanatory power of the model to the p <.05 level. Finally, in Step 5 the interaction
between level of extrinsic motivation and OCD symptom severity (i.e., Ext X Y-BOCS)
was entered as a final predictor. This interaction term was not significant and its
inclusion did not significantly improve the explanatory power of the model. Given that
the additions of interactions in Step 4 and Step 5 were found to be non-significant, Step 3
should be interpreted as the final model.
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Table 7
Summary of Hierarchical Multiple Regression Analysis for Level of Extrinsic Motivation for Treatment and Control Variables
Predicting OCD Treatment Outcome (N = 142)
Step 1
Variable
Y-BOCS at
admission
Length of Treatment

B

Step 2
β

SE B

.437

.085

.019

.017

.401***
.083

BDI score at
admission
Extrinsic motivation

B

SE B

Step 3
β

.019

.322**
*
.017 .085

.097

.056

.351

.098

.153t

B

SE B

β

.299

.100

.014

.017

.275**
*
.061

.100

.056

.158 t

1.243

.613

.162*

Ext x BDI
Ext x Y-BOCS
R2

.177***

.194***

Change in R2

.218***

.017
.023*
Note: Y-BOCS at admission, BDI score at admission and extrinsic motivation were centered at their means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10
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Table 7
Continued.
Step 4
Variable

B

SE B

Y-BOCS at
admission
Length of
Treatment
BDI score at
admission
Extrinsic
motivation
Ext x BDI

.298

.101

.014

Step 5
β

.303

SE B

β

.017

.274**
*
.063

.015

.278**
*
.017 .069

.100

.056

.158t

.100

.056

.158t

1.252

.618

.164*

1.131

.624

.148t

.008

.050

.013

-.019

.055

-.030

.125

.099

.106

Ext x Y-BOCS
R2

B

.218***

.100

.227***

Change in R2

.000
.009
Note: Y-BOCS at admission, BDI score at admission and extrinsic motivation were
centered at their means.
Note. *p < .05. **p < .01. ***p <.001. tp < .10
Discussion and Interpretation of Results for Question Three:
The third research question addressed the extent to which level of level of
extrinsic motivation for treatment predicted treatment outcome for patients receiving
intensive cognitive-behavioral therapy for OCD. Results of this study indicate that level
of extrinsic motivation was a significant predictor of OCD treatment outcome when
controlling for length of treatment, baseline levels of OCD symptoms, and baseline
depressive symptoms. Furthermore, a higher level of extrinsic motivation was associated
with poorer OCD treatment outcome. Prior to this study, researchers in the mental health
field have focused much of their attention on the role of intrinsic motivation in predicting
treatment response (Britton, Williams, & Connor, 2008; Nakagami et al., 2008; Ryan &
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Deci, 2000). Few studies have investigated the role of externally motivated factors in
treatment response, and no study to date has explored the role of extrinsic motivation in
predicting OCD treatment outcome. The results of this study are generally consistent
with the few studies that have explored this relationship.
Thus far, the few studies that have investigated the role of extrinsic or external
motivation for treatment have been in the substance-abuse and health-related treatment
literature. For example, in a study which examined the relationship between external
motivation and treatment outcomes in a methadone maintenance program for opioid–
dependent patients, patients who were externally motivated for treatment had higher
relapse rates (as evidenced by failed urine screens) and poorer attendance (Zeldman,
Ryan, and Fiscella, 2004). Results of this study also identified a particular subgroup of
noncompliant individuals for whom the presence of high level of extrinsic motivation and
low level of intrinsic motivation severely undermined treatment attendance and was
associated with the greatest degree of relapse. Furthermore, Williams, Grow, Freedman,
Ryan, and Deci (1996) found that morbidly obese patients in a weight-loss program who
reported less internal (i.e., intrinsic) and more external (i.e., extrinsic) reasons for
treatment experienced less weight loss and had difficulties maintaining their weight over
a 2-year period. The results of the present study extend these findings to the realm of
mental health treatment, specifically OCD treatment.
The findings of the present study are consistent with Self Determination Theory
(SDT; Deci & Ryan, 1985, 2000) in which the key concept is autonomous motivation.
According to Self Determination Theory, people are said to be autonomously motivated
when they experience themselves as having freely chosen their goals and the choice is
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felt to emanate from themselves. In contrast, people experience controlled or extrinsic
motivation when they feel that their choices do not emanate from themselves, but rather
reflect internal (e.g., guilt) or external pressures (e.g., others’ demands). Individuals
entering treatment for OCD with a high level of extrinsic motivation may feel pressured
to engage in the program. They may be entering treatment to gain the approval or
disapproval of significant others, or to avoid feelings of guilt and self-reproach.
Given that OCD treatment is experienced by patients as difficult and aversive
(Maltby & Tolin, 2003), it is unlikely that patients would enter treatment purely for
intrinsic purposes; external motivating factors are likely present for each patient. Indeed,
the majority of patients in this study reported some degree of extrinsic motivation at
admission. However, the findings in this study suggest that a higher level of extrinsic
motivation at the outset of treatment predicted poorer treatment outcome. From a clinical
standpoint, this finding suggests that treatment would have a different outcome for the
patient who responds to the question, “What brings you to seek OCD treatment?” by
stating, “My spouse told me I have to go into therapy or else…” compared with the
patient who responds, “I have been thinking about my life and realize that I need to make
changes to confront my OCD if I want to be the person I intend to be.” The former
response exemplifies a highly controlled, extrinsically motivated reason, and the latter
response a more autonomous or intrinsically motivated reason for entering treatment.
It may be that individuals who entered treatment under external social pressure
(i.e., level of extrinsic motivation) experienced OCD treatment as less in line with their
own personal goals, and experienced internal conflict during the treatment process.
Extrinsically motivated patients may have failed to internalize the responsibility for
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confronting their symptoms, and only half-heartedly engaged in the treatment process to
appease the demands of others. Furthermore, extrinsically motivated patients may have
experienced an external locus of causality; that is, they may not have attributed treatment
gains made during the course of therapy to their own efforts, but instead explained them
away as “just doing the treatment because I was told to.” More research is needed to
investigate the specific external motivating factors experienced by patients and the
mechanism by which these factors may undermine treatment.
Research Question Four (Q4): To what extent did level of motivation predict treatment
dropout for patients receiving intensive treatment for obsessive-compulsive disorder?
This research question assessed the extent to which motivation was related to
treatment dropout for individuals receiving treatment for OCD. Treatment dropout for
this study was defined as having been discharged from treatment within two weeks
following admission. Of the 142 participants in this study, 5 individuals (3.5%) left the
OCDI prior to the two-week point. Given the relatively small number of treatment
dropouts, descriptive data are presented (see Table 8) in lieu of statistical analyses
involving prediction (i.e., logistic regression).
Of the 5 participants who left the program prior to the two week point, 3
participants (NC 1, NC 2, and NC 3) did not experience substantial treatment gains.
Participant NC1, despite having the highest overall motivation score of all treatment
dropouts (TSRQ = 51), experienced the poorest treatment outcome with increases in both
OCD symptoms (change in Y-BOCS = +4) and depressive symptoms (change in BDI =
+6) between admission and discharge. Interestingly, participant NC1 was also the only
patient of the 5 treatment dropouts to report higher scores on the extrinsic motivation
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subscale (3.8) than on the intrinsic motivation subscale (3.0) at admission. Participants
NC2 and NC3 were the two participants with the shortest stays in the sample, with
participant NC2 staying a total of 2 days in the treatment program and participant NC3
exiting the program after one day. A qualitative examination of the exit interview data
for these two participants indicated a reluctance to engage in the intensity of the treatment
program. Participant NC2 reported that “although [she] wanted to get better, [she was]
not ready or willing” to perform the behavioral tasks required. Participant NC3 stated
that he felt “very depressed” and that the treatment “would be too much for [him] at this
time.”
Interestingly, not all of the participants who left the treatment program early had
unfavorable treatment outcomes. Of the 5 participants who left the program prior to the
two- week point, 2 of the participants appeared to experience significant treatment gains
and good overall treatment outcomes. As illustrated in Table 8, participant NC 4
experienced a drop in Y-BOCS of 22 points, representing approximately a 67% change in
overall Y-BOCS and substantial improvement in OCD symptoms. Participant NC 5 also
experienced a substantial improvement in OCD symptoms, as evidenced by a 23-point
decrease in Y-BOCS from admission to discharge, representing an 88% change in overall
Y-BOCS. Moreover, in conjunction with improvements in OCD symptoms, participants
NC4 and NC5 experienced substantial reduction in depressive symptoms as evidenced by
substantial decreases in BDI scores from admission to discharge. These data, although
limited due to the small sample, may indicate that the arbitrary designation of “treatment
dropout,” as defined by leaving the program prior to 2 weeks, may not have been
appropriate for this particular sample.
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Table 8
Descriptive Data for Non-Completing Participants* (N = 5)

Participant

Length
of
Treat
ment

Y-BOCS score

BDI score

Total
TSRQ

Intrinsic
Subscale

Extrinsic
Subscale

(days)
Admission
NonResponders
NC 1

Discharge Admission

Discharge

9

24

28

12

18

51

3.0

3.8

NC 2

2

26

22

17

10

33

5.0

1.8

NC 3

1

30

29

21

31

49

4.0

2.8

4.0
(4.4)

26.7 (3.1)

26.3 (3.8)

16.6 (5.2)

20.0
(10.5)

44.3
(9.9)

4.0 (1.0)

2.8 (1.0)

Responders**
NC 4

8

33

11

35

13

46

4.0

2.4

NC 5

13

26

3

18

4

39

4.0

2.0

Mean (SD)

8.5 (4.5)
42.5
4.0 (0.0)
2.2 (.28)
10.5
29.5 (4.5)
7.0 (5.7) 26.5 (8.5)
(4.9)
(3.5)
Note. * Non-completion of the treatment program is defined by exiting the program prior to 2 weeks.
** Responder to treatment is defined by >25% decrease in Y-BOCS scores from admission to discharge.
Mean (SD)
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Discussion and Interpretation of Results for Question Four:
The final research question for the study assessed the extent to which level of
motivation was related to treatment dropout for individuals receiving treatment for OCD.
Given the small number of individuals who dropped out of the treatment prematurely
(i.e., 5 patients or 3.5% of the sample), descriptive data were presented in lieu of
statistical analyses involving prediction (i.e., logistic regression). Although
generalization from these results to the population is not possible with the limited number
of treatment dropouts, a close examination of the descriptive data does reveal some
information that may assist in future studies.
Of the five patients who left the program prior to the two-week point, two patients
experienced significant treatment gains. One participant reported a drop in Y-BOCS
score of 22 points, representing approximately a 67% reduction in OCD symptoms.
Another patient experienced a 23-point decrease in Y-BOCS score from admission to
discharge, representing an 88% change in overall Y-BOCS score, reflecting a substantial
reduction in symptoms. Although these two patients may have left treatment prior to two
weeks, they do not necessarily represent “treatment dropouts;” rather they may represent
individuals who were able to benefit from the treatment rapidly and thus leave prior to
two weeks due to positive experiences.
Of the 5 patients who left the program prior to the two-week point, 3 patients did
not experience substantial reductions in their OCD symptoms, as defined by a greater
than 25% decrease in Y-BOCS scores. Two patients experienced minor reductions in
symptoms, while one patient experienced an increase in symptoms. Furthermore, two of
the three dropout patients appeared to have initial levels of overall motivation that were
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above average for the sample. Interestingly, despite their reportedly above average levels
of overall motivation at admission, these patients also reported substantial increases in
their depressive symptoms from the time of admission to the time of discharge. It may be
the case that although these patients reported above average levels of overall motivation
at intake, their motivation was undermined by an abrupt intensification of depressive
symptoms soon after admission. The contributing factors to this increase in depressive
symptoms are unclear at this time and warrant further investigation. It may be the case
that a select subgroup of OCD patients experiences a significant sudden rise in depressive
symptoms when faced with the overwhelming task of confronting fearful stimuli during
exposure sessions in an intensive treatment setting. Other researchers (Hayes, Beevers,
Feldman, Laurenceau, & Perlman, 2005) discovered a similar symptom pattern in a study
of exposure-based cognitive therapy for depression. A discontinuous pattern of change
was discovered in which the course of therapy was characterized by depression spikes,
large increases in depressive symptoms during the exposure phase of therapy. Moreover,
these depression spikes were often followed by a decrease in anxiety and depressive
symptoms. It is possible that these depression spikes also occur in the course of
exposure-based treatment for OCD, and may contribute to treatment dropout.
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CHAPTER 4
CONCLUSIONS, TREATMENT IMPLICATIONS, LIMITATIONS,
AND FUTURE DIRECTIONS

Conclusions
This study investigated the role of motivation in the treatment of individuals
hospitalized for severe OCD, specifically, the extent to which an individual’s motivation
for treatment and motivational orientation (intrinsic or extrinsic motivation) predict OCD
treatment response. Results of this study are generally consistent with past research
highlighting the importance of motivation as a factor related to treatment outcome.
Although the results of this study confirm that motivation plays a significant role in the
treatment of individuals with severe OCD, the present findings indicate that the
relationship of motivation to OCD treatment outcome may be more complex than
documented in previous studies in health-related domains.
The first research question in the present study explored the extent to which level
of overall motivation for treatment predicted treatment outcome for patients receiving
intensive therapy for OCD in a residential treatment setting. Contrary to previous
findings in health-related domains, results of this study do not support the hypothesis that
a higher level of overall motivation for treatment at admission is predictive of OCD
treatment response. However, results of the present study indicate that an individual’s
motivational orientation (i.e., baseline level of intrinsic or extrinsic motivation) can serve
as a significant predictor OCD treatment response.
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The second research question investigated the extent to which level of intrinsic
motivation predicted treatment outcome for patients receiving intensive therapy for OCD.
It was hypothesized that level of intrinsic motivation would predict treatment outcome
when controlling for length of treatment, baseline level of OCD symptoms, and baseline
level of depressive symptoms. Results indicate that the relationship between intrinsic
motivation and treatment outcome is complex and dependent upon the level of severity of
OCD symptoms at the outset of treatment. More specifically, patients entering treatment
with a high level of OCD symptom severity and a low level of intrinsic motivation have
poorer treatment outcomes, whereas patients with a high level of symptom severity who
also reported a high level of intrinsic motivation appear to have better treatment
outcomes. In other words, a high level of intrinsic motivation at the outset of treatment
may be a particularly important ingredient in promoting positive treatment outcome when
OCD symptoms are severe.
The third research question investigated the extent to which level of extrinsic
motivation predicted treatment outcome for patients receiving intensive therapy for OCD.
In the present study the level of extrinsic motivation was a significant predictor of OCD
treatment outcome when controlling for length of treatment, baseline level of OCD
symptoms, and baseline depressive symptoms. Furthermore, a higher level of extrinsic
motivation was associated with poorer OCD treatment outcome. This finding is
consistent with studies in the substance-abuse and health-related domains where extrinsic
motivation (i.e., external pressure) is a common predictor of poor treatment response.
The present study extends these findings to the realm of mental health treatment,
specifically OCD treatment. More research is needed to investigate the specific intrinsic
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and extrinsic motivating factors experienced by patients and the mechanism by which
these factors enhance or undermine treatment.
The final research question assessed the extent to which level of motivation was
related to treatment dropout for individuals receiving intensive treatment for OCD.
Given the small number of patients in this study who dropped out of treatment
prematurely (i.e., 5 patients or 3.5% of the sample), the generalizability of the results
pertaining to this question are limited. Nevertheless, descriptive analysis revealed that an
abrupt increase in depressive symptoms occurred immediately following admission with
patients who left the program prematurely. Future research with larger sample sizes is
needed to investigate what factors prompt some patients to drop out of treatment, prior to
when the actual interventions have begun.

Treatment Implications
The findings of this study have important treatment implications pertaining to
efforts to maximize OCD treatment response. Enhancing response to effective treatments
is a priority for clinical research. Recently, researchers and clinicians have identified
patients’ ambivalence as a significant obstacle to the effective treatment of anxiety and
OCD (Tolin & Maltby, 2008; Westra & Dozois, 2008). Research with patients with
anxiety disorders such as panic disorder (Dozois, Westra, Collins, Fung, & Garry, 2004)
and OCD (Franklin & Foa, 2002) suggests that many individuals enter treatment with
significant reservations about engaging in therapy. Furthermore, many patients with
OCD have strong and mixed reactions to the idea of engaging in treatment involving
exposure and response prevention techniques (ERP). Indeed, many OCD patients refuse
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ERP due to fear or apprehension about the difficulty and intensity of ERP (Maltby &
Tolin; 2005). In many respects, this is not surprising, as ERP is the phenomenological
antithesis to the maladaptive coping strategy that most OCD patients have used (i.e.,
avoiding anxiety provoking situations and performing extensive rituals to reduce their
anxiety). As such, individuals with OCD may enter treatment with varying levels of
ambivalence about change and motivation to address their symptoms. Furthermore,
individuals come to treatment with differing reasons for addressing their OCD symptoms.
Some of these reasons for change are more internally motivated (e.g., “I need to change
because I envision a much better life for myself without my OCD symptoms.”), while
other reasons may be more externally motivated (e.g., “I am here at treatment because my
wife said she would leave me if I refused treatment.”). Findings from the present study
indicate that reasons for initiating treatment, or the patient’s motivational orientation (i.e.,
level of intrinsic and extrinsic motivation), play a role in determining the extent to which
they benefit from intensive OCD treatment.
The present study suggests that assessing an individual’s level of intrinsic and
extrinsic motivation for OCD treatment should be viewed as an essential component in
the treatment process. From a clinical standpoint, identifying an individual’s
motivational orientation at the outset of treatment may help to maximize treatment gains
and minimize negative treatment experiences. For example, individuals who are deemed
to be more extrinsically motivated may benefit from interventions that target increasing
self-motivating factors (e.g., Motivational Interviewing (MI; Miller & Rollnick, 2002)
prior to engaging in exposure tasks). A primary goal of MI is to increase intrinsic
motivation to change -- that which arises from personal goals and values rather than from
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external sources such as the attempts of others to persuade, cajole, or coerce the person to
change. MI has become an effective approach for promoting behavior change, initially in
the area of alcohol and other substance abuse, and more recently for a wider range of
problems. It is a client-centered (Rogers, 1951) method that neither persuades nor
coerces patients to change, but instead attempts to explore and resolve their ambivalence,
allowing them to decide for themselves whether to change. MI works on the assumptions
that many patients who seek therapy are ambivalent about change, and that motivation
may ebb and flow during the course of therapy. A therapist utilizing MI techniques
works toward creating an atmosphere in which the client, rather than the therapist,
becomes the advocate for change as well as the primary agent for change (Arkowitz &
Miller, 2008). For patients who are identified as having a low level of intrinsic
motivation and a high level of extrinsic motivation, the results of this study indicate that
integrating motivational enhancement interventions (e.g., MI) may be particularly
important for OCD treatment success.

Limitations of Study
Several limitations should be noted when interpreting the results of this study.
Generalizability is limited by several factors. First, participants in this study represent a
select subset of OCD patients with a history of severe and treatment-refractory OCD, and
thus may not have been representative of individuals with OCD in general clinical
practice. Many of the patients who attend the OCDI treatment program have tried
numerous forms of treatment (i.e., psychotropic medications and various trials of
psychotherapy) without having experienced successful outcomes. Therefore, this sample
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represents a specific subset of OCD sufferers whose findings may not be generalizable to
the typical OCD patient. Furthermore, given the treatment refractoriness of this
population, it is possible that motivation may have played a substantially different role in
the treatment process when compared to a less severe and less treatment-refractory OCD
population. For example, one would expect that prior unsuccessful experiences with
OCD treatment may have influenced pre-treatment level of motivation. Additionally,
there may have been other factors inherent to this particular treatment-refractory
population (i.e., higher incidence of delusional beliefs, lack of insight into symptoms,
higher incidence of cognitive deficits) which may have influenced motivation, thereby
making the results less generalizable.
Second, the treatment in this study may not reflect treatment as it typically occurs
in the community. The OCDI is a comprehensive, intensive, and highly-structured
residential treatment setting where patients are challenged to confront their symptoms
from the time they awaken until they sleep (Osgood-Hynes, Riemann, Björgvinsson,
2004). Standard cognitive-behavioral treatment for OCD is typically conducted in a less
structured and less intensive outpatient setting consisting of weekly office visits to a
therapist (Abramowitz, Schwartz, & Furr, 2003). The role of motivation in OCD
treatment response may change given the treatment setting and the intensity of the
therapy delivered. For example, intrinsic motivation may be more important in the
outpatient treatment setting where more emphasis is placed on self-directed homework
assignments between sessions.
The results of this study may have been unduly influenced by the timing and
methods used for assessing motivation. As mentioned previously, currently there is no
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measure that assesses motivation for OCD treatment. Therefore, the Treatment SelfRegulation Questionnaire, which was adapted to assess this construct, was developed to
evaluate motivation in studies investigating health-related issues (e.g., smoking cessation,
diet improvement, regular exercising, and drinking responsibly); prior to this study the
TSRQ had not been applied to the treatment of anxiety or OCD. Although the results of
this study failed to indicate that level of overall motivation is a significant predictor of
OCD treatment response, it is possible that the Treatment Self Regulation Questionnaire
was not sensitive to the construct being assessed, and therefore did not adequately capture
motivation for OCD treatment. For example, one item on the TSRQ states, “I have
remained in treatment because I would have felt like a failure if I didn’t.” Participants
were asked to rate this item on a Likert-type scale of 1-7 with higher scores indicating
higher motivation. One might argue that while this question may measure motivational
orientation, it does not necessarily measure the specific goal of alleviating OCD
symptoms. Therefore, the TSRQ may serve as a more sensitive measure for assessing the
type or quality of motivation (i.e., intrinsic or extrinsic), rather than for evaluating the
overall level of motivation for OCD treatment. Future studies may benefit from use of a
measure designed to assess motivation as it applies specifically to OCD.
This study also has limitations inherent in the use self-report questionnaires. Each
measure used in this study demonstrated adequate validity and reliability; however, by
definition these self-report measures assess what participants believe to be true or what
they are willing to communicate. The exclusive use of a self-report measure to assess
motivation could have introduced response bias, particularly given the social context and
timing in which patients were asked to rate their level of motivation (i.e., upon admission
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to the OCDI program). There are a number of reasons why self-ratings of motivation
may be intentionally or unintentionally biased during the admission process, such as
social desirability response bias, which has not been examined to date. The TSRQ may
be susceptible to a social desirability response bias particularly when it asks respondents
to endorse items reflecting unpopular self-perceptions (e.g., ‘‘I have remained in
treatment because of the amount of money I have invested in this program.”), as well as
desirable attitudes (e.g., ‘‘I have remained in treatment because it is a challenge to
accomplish my goal.”). Given that patients are administered the TSRQ at the outset of
treatment, they may be invested in portraying themselves as eager to address their
symptoms and as fully invested in the program. Future studies may benefit from
incorporating an additional clinician-rated measure of the patient’s level of motivation for
treatment as a supplement to self-report measures.
Moreover, the participant’s self-assessment of motivation at admission may differ
significantly from his or her assessment after participating fully in the treatment for a
period of time. Some researchers have suggested that motivation is by no means a static
construct; rather it involves a dynamic process which may wax and wane over the course
of treatment (Deci & Ryan, 2000; Miller & Rollnick, 2002; Prochaska & Norcross,
2002). Of note, the measure used in this study to assess motivation was administered at
the outset of treatment and prior to the implementation of interventions. Therefore, the
findings of this study may be more reflective of the patient’s ‘motivation to enter
treatment’ rather than his or her ‘motivation to engage in treatment.’
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Future Directions
Understanding, enhancing, and sustaining motivation for OCD treatment are
critical challenges that need to be addressed in efforts to improve the effectiveness of
existing OCD interventions. Findings of the present study suggest that motivation is a
key component in the OCD treatment process and warrants further investigation. Many
questions remain unexplored regarding the mechanisms by which motivation influences
the OCD treatment process. Does motivation for OCD treatment fluctuate over the
course of treatment? Do specific patterns of change lead to better or worse treatment
outcomes? For example, some individuals may enter treatment with a higher level of
extrinsic motivation; however, during the first few weeks of treatment they may
experience a shift in their motivational orientation, resulting in a higher level of intrinsic
motivation and a lower level of extrinsic motivation. Future studies would benefit from
investigating the longitudinal course of motivation during the process of treatment.
There may be other relational factors that this study did not investigate which are
intimately tied to a patient’s level of motivation and treatment outcome. For example,
many psychotherapy studies have demonstrated that a good therapeutic alliance predicts
a favorable outcome (Constantino, Castonguay, & Schut, 2002; Horvath, 1994; Roth &
Fonagy, 1996; Waddington, 2002), yet the therapeutic alliance has yet to be fully
examined in regard to OCD treatment. It may be the case that the quality of the
therapeutic alliance is related to motivation for OCD treatment. Indeed, one might expect
that the therapist’s ability to enhance motivation through the use of the therapeutic
alliance would be associated with better treatment outcome. Recent research suggests
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that the way a therapist responds to a patient’s ambivalence during therapy is critical to
treatment outcome (Huppert, Barlow, Gorman, Shear, & Woods, 2006). In situations in
which a strong therapeutic alliance has been established, the patient with OCD may feel
more trusting in the treatment process and more motivated to comply with difficult ERP
tasks. Future studies which explore the relationship between the therapeutic alliance and
motivation for OCD treatment may shed light on the role of relational factors in OCD
treatment.
Patients’ expectancies of treatment effectiveness is another variable that has
proven to be a powerful predictor of psychotherapy outcome (Kirsch, 1999; Sotsky et al.,
1991; Weinberger & Eig, 1999). It is reasonable to assume that an individual’s
motivation for OCD treatment would be related to how effective he or she believes the
treatment will be. It is unlikely that an individual would have a high level of motivation
if he or she did not feel that the treatment would reduce symptoms. As mentioned
previously, exposure and response prevention therapy is often experienced by the patient
as aversive, and requires that patients confront their worst fears. It requires a ‘leap of
faith’ in which the patient has to endure substantial distress in order to experience
positive outcome. Patients must have some level of trust in the treatment process and
hope that the therapy will work. Given the significant amount of literature suggesting
that patients' treatment expectations remain important contributors to psychotherapy
outcome (for a review see Greenberg, Constantino, & Bruce, 2006), future research
should consider exploring this crucial factor and how it relates to motivation for OCD
treatment.
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This study also highlights the importance of developing a valid measure to assess
motivation for OCD treatment. As mentioned previously, the present study adopted a
measure used in health-related studies to assess motivation for treatment (i.e., the
Treatment Self-Regulation Questionnaire). The motivation to confront challenges
specific to OCD may be qualitatively different than the motivation required in the
treatment of health-related problems. For example, in OCD treatment a patient who has
contamination fears may be asked to voluntarily contaminate his or her hands by
touching items in a wastebasket and resisting the urge to wash. The motivation required
to initiate and engage in such aversive tasks may differ from the type of motivation
required to abstain from alcohol or smoking. Although the TSRQ was adequate for the
present study, future studies would benefit from a measure specifically designed to gauge
motivation for OCD treatment.
Findings from this study will help in the development of improved interventions
for patients who are non-responsive to empirically supported therapeutic interventions
(CBT and ERP). As mentioned previously, despite strong evidence that OCD can be
effectively treated with ERP and CBT, many individuals do not benefit from these
interventions. Once a clearer understanding emerges of the role and mechanisms by
which motivation is related to the treatment process, interventions aimed at facilitating
and enhancing motivation for ERP can be developed.
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APPENDIX A
OCD INSTITUTE ADMISSION DEMOGRAPHIC QUESTIONAIRRE
OCD INSTITUTE
115 Mill Street, Belmont, MA 02478
PATIENT INFORMATION
NAME__________________________ SS#___________________________________
ADDRESS _________________________________ DOB ______________Age
City, State, Zip ___________________________ Sex M F Marital Status S / M / D / W
Height _________________ Weight ____________Occupation:____________________
TELEPHONE: (HOME)______________________(WORK)__________________
(CELL)________________
Email Address _______________________________________________________
Living with ______________________________________
Education_______________________________
(Highest Degree Completed)
EMERGENCY CONTACT: Name and phone number
________________________________________
Referred by:
__________________________________________________________________
Current Treators (please include psychiatrist, therapist, primary care physician, etc.)
____________________________ ___________________________
___________________________
Name
Role
Phone
____________________________ ___________________________
___________________________
Name
Role
Phone
____________________________ ___________________________
___________________________
Name
Role
Phone
Insurance Information
PLEASE INCLUDE PHOTOCOPY OF FRONT AND BACK OF ID CARD
Insurance Company Name ____________________________________Phone
_____________________
Name of Insured ________________________________Group Number
__________________________
ID Number ____________________________ Policy
Number_________________________________
Insured’s DOB __________________Insured’s SS #____________________________
Insured’s Place of
Employment___________________________________________________________
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Contact Person ______________________ Phone ______________________________
Coverage for Psychiatric Services (inpatient and
outpatient)_______________________________________________________________
Will you be self-paying? Y/N
Please include a photocopy of your insurance card (front and back)
I authorize members of the OCD Institute staff to speak with my insurance company and
treatorslisted above in service of my application to the program
_____________________________________________________________________
Patient’s Signature Date
Past Medical History
ALLERGIES
Do you have allergies to any medication? Yes / No
If so, what medication?__________________________________________________
If so, what type of reaction did you have?____________________________________
MEDICAL ILLNESSES
Have you in the past or do you now have any medical illnesses?
Yes / No
What type of illness?
______________________________________________________________
Do you have difficulty with urinary/fecal incontinence? ________________________
SURGERY
Have you ever had surgery? Yes / No
Type and dates of surgery
__________________________________________________________
Past Psychiatric History
HOSPITALIZATIONS
Have you ever been hospitalized for a psychiatric illness? Yes / No
If so, what was the diagnosis and when were you hospitalized?
_______________________________________________________________________
OUTPATIENT PSYCHIATRIC TREATMENT
Have you been in therapy for a psychiatric condition? Yes / No
If so, where and when?_______________________________________________
What type of therapy did you have? (E.g., medication, psychodynamic, behavioral,
other): (if behavioral, please rate on a scale of 0-10 how successful it
was):___________________________________________________________________
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Medication History
What medications are you presently taking? (Include medical and psychotropic
medications, aswell as dosages for all)
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Have you used illegal drugs? Yes___ No___
Are you using them now? Yes ___ No ___
If so, what kinds of drugs and when (how much?)
________________________________________________________________________
__________________________________________________

Do you drink alcohol? Yes/No
If so, how much?
_____________________________________________________________
Has anyone considered you an alcoholic or drug abuser?
_____________________________________________________________
Family History
Has anyone in your family ever been diagnosed with a psychiatric illness? Yes/No
Explain:
______________________________________________________________________
________________________________________________________________________
Has anyone in your family attempted suicide?
________________________________________________________________________
________________________________________________________________________
Marital Status: Single ____Married ____Partner ____ Separated ____Divorced _____
If married, or with a partner: How long? ________________________________
Husband/Wife/Partner’s Age _________________________________________
Occupation of Husband/Wife/Partner __________________________________
If separated/divorced: Date __________________________________________
Reason: ___________________________________________________________
Children: Names/Ages:
Referral
What types of obsessive-compulsive behaviors do you have?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
At what age did the obsessions or compulsions begin?
________________________________________________________________________
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What specific situations or objects trigger your compulsive rituals or obsessions?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What thoughts, images or impulses trigger your compulsive rituals or obsessions?
________________________________________________________________________
________________________________________________________________________
_____________________________________________________________
Is there anything you avoid doing or thinking?
________________________________________________________________________
________________________________________________________________________
____________________________
________________________________________________________________________
______________
TRAUMA HISTORY:
1. Do you have a history of trauma? (I.e., physical sexual abuse)
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
2. Has anyone ever diagnosed you with Post-Traumatic Stress Disorder (PTSD)?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
3. Do you engage in self-injurious behavior? (I.e. cutting, burning)
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
JOB HISTORY
List the jobs you have held and their dates. Then note which aspects of each job were the
mostpleasurable for you (e.g., working with people, type of work, etc.) and which aspects
gave you the most anxiety or trouble.
Dates
Job
Titles
Liked
Disliked
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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Below, please add anything not covered in this questionnaire that you feel could help us
understand your problem. Please include why you want to come to the program (as
opposed to why others may want you to come).
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
If there is a family member currently living with you, please have them comment on their
observations of your behaviors, the ways in which they may accommodate your OCD and
how your OCD affects the household.

Legal History:
1. Has anyone ever reported you to the police? Yes _____ No _____
2. Have you ever been arrested? Yes _____ No _____
If Yes, for what?
________________________________________________________________________
________________________________________________________________________
3. Have legal charges ever been brought against you? Yes _____ No _____
4. Have you ever been involved with the legal system in any
way (e.g., probation, parole, hearing pending, etc)? Yes _____ No _____
If yes, please explain briefly here.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
5. Are you currently involved with the legal system in any
way (e.g., probation, parole, hearing pending, etc)? Yes _____ No _____
If yes, please explain briefly here.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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APPROVED
MCLEAN HOSPITAL
IRB DATED 6/22/07

Thank you for taking the time to complete the following information. Completion of the
following questionnaires serves two important functions. Foremost, it helps the admitting
team to understand your symptoms for consideration for admission to the OCD Institute.
Secondly, if you give permission, we will combine this information with that of other
applicants to conduct research studies to learn more about the nature of OCD and the
components of treatment success. If you would like to have your information included in
a research study, please check the box below. If your information is included, your
confidentiality will be maintained and no identifying data for you will be included in any
publications or presentations.
Please check one of the boxes below:
Yes, I agree to have my information included for future research studies. I
understand that no identifying information about me will be included in this research.

No, do not include my information in the research database.

________________________________________ _______________________
Name
Date
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APPENDIX B
PARTNERS ETHNICITY QUESTIONNAIRE

How would you describe your ethnicity/ race? You may select all that apply.
___ Hispanic or Latino
A person of Cuban, Mexican, Puerto Rican, South or Central American, or other
Spanish culture or origin regardless of race.
___ White (Not Hispanic or Latino)
A person having origins in any of the original peoples of Europe, the Middle East,
or North Africa.
___ Black or African American (Not Hispanic or Latino)
A person having origins in any of the black racial groups in Africa.
___ Asian (Not Hispanic or Latino)
A person having origins in any of the original peoples of the Far East, Southeast
Asia, or the Indian subcontinent including, for example Cambodia, China, India,
Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam.
___ American Indian or Alaska Native (Not Hispanic or Latino)
A person having origins in any of the original peoples of North or South America
(including Central America), and who maintain tribal affiliation or community
attachment.
___ Native Hawaiian or Other Pacific Islander (Not Hispanic or Latino)
A person having origins in any of the original peoples of Hawaii, Guam, Samoa,
or other Pacific Islands.
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APPENDIX C
YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS)
"I am now going to ask several questions about your obsessive thoughts." [Make specific
reference to the patient's target obsessions.]

1. TIME OCCUPED BY OBSESSIVE THOUGHTS
0 = None.
1 = Mild, less than 1 hr/day or occasional intrusion.
2 = Moderate, 1 to 3 hrs/day or frequent intrusion.
3 = Severe, greater than 3 and up to 8 hrs/day or very frequent intrusion.
4 = Extreme, greater than 8 hrs/day or near constant intrusion.

Q: How much of your time is occupied by obsessive thoughts? [When
obsessions occur as brief, intermittent intrusions, it may be difficult to assess
time occupied by them in terms of total hours. In such cases, estimate time by
determining how frequently they occur. Consider both the number of times the
intrusions occur and how many hours of the day are affected. Ask:1 How
frequently do the obsessive thoughts occur? [Be sure to exclude ruminations
and preoccupations which, unlike obsessions, are ego-syntonic and rational
(but exaggerated).]

0
1
2
3
4

1b. OBSESSION-FREE INTERVAL (not included in total score)
0 = No symptoms.
1 = Long symptom-free interval, more than 8 consecutive hours/day symptom-free.
2 = Moderately long symptom-free interval, more than 3 and up to 8 consecutive
hours/day symptom-free.
3 = Short symptom-free interval, from I to 3 consecutive hours/day symptom-free.
4 = Extremely short symptom-free interval, less than I consecutive hour/day symptomfree.

Q: On the average, what is the longest number of consecutive waking hours per
day that you are completely free of obsessive thoughts? [If necessary, ask:1
What is the longest block of time in which obsessive thoughts are absent?
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0
1
2
3
4

2. INTERFERENCE DUE TO OBSESSIVE THOUGHTS
0 = None.
1 = Mild, slight interference with social or occupational activities, but overall
performance not impaired.
2 = Moderate, definite interference with social or occupational performance, but still
manageable.
3 = Severe, causes substantial impairment in social or occupational performance.
4 - Extreme, incapacitating.

Q: How much do your obsessive thoughts interfere with your social or work
(or role) functioning? Is there anything that you don't do because of them? [If
currently not working determine how much performance would be affected if
patient were employed.]

0
1
2
3
4

3. DISTRESS ASSOCIATED W1TH OBSESSIVE THOUGHTS
0 = None
1 = Mild, not too disturbing
2 = Moderate, disturbing, but still manageable
3 = Severe, very disturbing
4 = Extreme, near constant and disabling distress

Q: How much distress do your obsessive thoughts cause you? [In most eases,
distress is equated with anxiety; however, patients may report that their
obsessions are "disturbing" but deny "anxiety." Only rate anxiety that seems
triggered by obsessions, not generalized anxiety or associated with other
conditions.]

4. RESISTANCE AGAINST OBSESSIONS
0 = Makes an effort to always resist, or symptoms so minimal doesn't need to actively
resist
1 = Tries to resist most of the time
2 = Makes some effort to resist
3 = Yields to all obsessions without attempting to control them, but does so with some
reluctance
4 = Completely and willingly yields to all obsessions
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0
1
2
3
4

Q: How much of an effort do you make to resist the obsessive thoughts? How
often do you try to disregard or turn your attention away from these thoughts as
they eater your mind? [Only rate effort made to resist, not success or failure in
actually controlling the obsessions. How much the patient resists the
obsessions may or may not correlate with his/her ability to control them. Note
that this item does not directly measure the severity of the intrusive thoughts;
rather it rates a manifestation of health, i.e., the effort the patient makes to
counteract the obsessions by means other than avoidance or the performance of
compulsions. Thus, the more the patient tries to resist, the less impaired is this
aspect of his/her functioning. There are "active" and “passive" forms of
resistance. Patients in behavioral therapy may be encouraged to counteract
their obsessive symptoms by not struggling against them (e.g., "just let the
thoughts come; passive opposition) or by intentionally bringing on the
disturbing thoughts. For the purposes of this item, consider use of these
behavioral techniques as forms of resistance. If the obsessions are minimal, the
patient may not feel the need to resist them. In such cases, a rating of "0"
should be given.]

0
1
2
3
4

5. DEGREE OF CONTROL OVER OBSESSIVE THOUGHTS
0 = Complete control.
1 = Much control, usually able to stop or divert obsessions with some effort and
concentration. 2 = Moderate control, sometimes able to stop or divert obsessions.
3 = Little control, rarely successful in stopping or dismissing obsessions, can only divert
attention with difficulty.
4 = No control, experienced as completely involuntary, rarely able to even momentarily
alter obsessive thinking.

Q: How much control do you have over your obsessive thoughts? How
successful are you in stopping or diverting your obsessive thinking? Can you
dismiss them? [In contrast to the preceding item on resistance, the ability of the
patient to control his obsessions is more closely related to the severity of the
intrusive thoughts.]
"The next several questions are about your compulsive behaviors." [Make specific
reference to the patient's target compulsions.]

90

0
1
2
3
4

6. TIME SPENT PERFORMING COMPULSIVE BEHAVIORS
0 = None
1 = Mild (spends less than I hr/day performing compulsions), or occasional performance
of compulsive behaviors.
2 = Moderate (speeds from I to 3 hrs/day performing compulsions), or frequent
performance of compulsive behaviors.
3 = Severe (spends more than 3 and up to 8 hrs/day performing compulsions), or very
frequent performance of compulsive behaviors.
4 = Extreme (spends more than 8 hrs/day performing compulsions), or near constant
performance of compulsive behaviors (too numerous to count).

Q: How much time do you spend performing compulsive behaviors? [When
rituals involving activities of daily living are chiefly present, ask:] How much
longer than most people does it take to complete routine activities because of
your rituals? [When compulsions occur as brief, intermittent behaviors, it may
difficult to assess time spent performing them in terms of total hours. In such
cases, estimate time by determining how frequently they are performed.
Consider both the number of times compulsions are performed and how many
hours of the day are affected. Count separate occurrences of compulsive
behaviors, not number of repetitions; e.g., a patient who goes into the bathroom
20 different times a day to wash his hands 5 times very quickly, performs
compulsions 20 times a day, not 5 or 5 x 20 = 100. Ask:] How frequently do
you perform compulsions? 1In most cases compulsions are observable
behaviors(e.g., hand washing), but some compulsions are covert (e.g., silent
checking).]

0
1
2
3
4

6b. COMPULSION-FREE INTERVAL(not included in total score)
0 = No symptoms.
1 = Long symptom-free interval, more than 8 consecutive hours/day symptom-free.
2 = Moderately long symptom-free interval, more than 3 and up to 8 consecutive
hours/day symptom-free.
3 = Short symptom-free interval, from I to 3 consecutive hours/day symptom-free.
4 = Extremely short symptom-free interval, less than I consecutive hour/day symptomfree.
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Q: On the average, what is the longest number of consecutive waking hours per
day that you are completely free of compulsive behavior? [If necessary, ask:]
What is the longest block of time in which compulsions are absent? different
times a day to wash his hands 5 times very quickly, performs compulsions 20
times a day, not 5 or 5 x 20 = 100. Ask:] How frequently do you perform
compulsions? In most cases compulsions are observable behaviors(e.g., land
washing), but some compulsions are covert (e.g., silent checking).]

0
1
2
3
4

7. INTERFERENCE DUE TO COMPULSIVE BEHAVIQRS
0 = None
1 = Mild, slight interference with social or occupational activities, but overall
performance not impaired
2 = Moderate, definite interference with social or occupational performance, but still
manageable
3 = Severe, causes substantial impairment in social or occupational performance
4 = Extreme, incapacitating
Q: How much do your compulsive behaviors interfere with your social or work
(or role) functioning? Is there anything that you don't do because of the
compulsions? [If currently not working determine how much performance
would be affected if patient were employed.]

0
1
2
3
4

8. DISTRESS ASSOCIATED WITH COMPULSIVE BEHAVIOR
0 = None
1 = Mild only slightly anxious if compulsions prevented, or only slight anxiety during
performance of compulsions
2 = Moderate, reports that anxiety would mount but remain manageable if compulsions
prevented, or that anxiety increases but remains manageable during performance of
compulsions
3 = Severe, prominent and very disturbing increase in anxiety if compulsions interrupted,
or prominent and very disturbing increase in anxiety during performance of
compulsions
4 = Extreme, incapacitating anxiety from any intervention aimed at modifying activity,
or incapacitating anxiety develops during performance of compulsions
Q: How would you feel if prevented from performing your compulsion(s)?
[Pause] How anxious would you become? [Rate degree of distress patient
would experience if performance of the compulsion were suddenly interrupted
without reassurance offered. In most, but not all cases, performing compulsions
reduces anxiety. If, in the judgement of the interviewer, anxiety is actually
reduced by preventing compulsions in the manner described above, then asked:
How anxious do you get while performing compulsions until you are satisfied
they are completed?
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0
1
2
3
4

9. RESISTANCE AGAINST COMPULSIONS
0 = Makes an effort to always resist, or symptoms so minimal doesn't need to actively
resist
1 = Tries to resist most of the time
2 = Makes some effort to resist
3 = Yields to almost all compulsions without attempting to control them, but does so with
some reluctance
4 = Completely and willingly yields to all compulsions

Q: How much of an effort do you make to resist the compulsions? I Only rate
effort made to resist, not success or failure in actually controlling the
compulsions. How much the patient resists the compulsions may or may not
correlate with his ability to control them. Note that this item does not directly
measure the severity of the compulsions; rather it rates a manifestation of
health, i.e., the effort the patient makes to counteract the compulsions. Thus,
the more the patient tries to resist, the less impaired is this aspect of his
functioning. If the compulsions are minimal, the patient may not feel the need
to resist them. In such cases, a rating of "0" should be given.]

0
1
2
3
4

10. DEGREE OF CONTROL OVER COMPULSIVE BEHAVIOR
1 = Much control, experiences pressure to perform the behavior but usually able to
exercise voluntary control over it.
2 = Moderate control, strong pressure to perform behavior, can control it only with
difficulty
3 = Little control, very strong drive to perform behavior, must be carried to completion,
can only delay with difficulty
4 = No control. drive to perform behavior experienced as completely involuntary and
overpowering, rarely able to even momentarily delay activity

Q: How strong is the drive to perform the compulsive behavior? [Pause] How
much control do you have over the compulsions? [In contrast to the preceding
item on resistance, the ability of the patient to control his compulsions is more
closely related to the severity of the compulsions.]
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0
1
2
3
4

APPENDIX D
TREATMENT SELF-REGULATION QUESTIONNAIRE (TSRQ)

The following questions relate to your reasons for continuing to participate in the OCD
treatment program. Different people have different reasons for being in such a program,
and we want to know how true each of these reasons is for you. There are two groups of
questions. The questions in each group pertain to the sentence that begins that group.
Please indicate how true each reason is for you, using the following scale:

1
2
not at all true

3

4
5
somewhat true

6

7
very true

A. I have remained in treatment:
1. Because I would have felt bad about myself if I didn't.
2. Because others would have been angry at me if I didn't.
3. Because I would have felt like a failure if I didn't.
4. Because I feel like it's the best way to help myself.
5. Because people would think I'm a weak person if I didn't.
6. Because I do not really feel like I can choose to leave the program.
7. Because it is a challenge to accomplish my goal.
8. Because of the amount of money I have invested in this program.
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B. I have been following the procedures of the program because:
9. I believe they help me solve my problem.
10. I have been worried that I would get in trouble with the staff if I didn't follow
all the guidelines.
11. I want others to see that I’m really trying to address my OCD.
12. It is important to me that my efforts succeed.
13. I feel guilty if I don't comply with all the procedures.
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APPENDIX E
BECK DEPRESSION INVENTORY (BDI)
On this questionnaire are groups of statements. Please read each group of statements
carefully. Then pick out the one statement in each group which best describes the way
you have been feeling the PAST WEEK including today. Circle the number beside the
statement you picked. If several statements in the group seem to apply equally well,
circle each one. Be sure to read all the statements in each group before making your
choice.

1.

0
1
2
3

I do not feel sad.
I feel sad.
I am sad all the time and can't snap out of it.
I am so sad or unhappy that I can't stand it.

2.

0
1
2
3

I am not particularly discouraged about the future.
I feel discouraged about the future.
I feel I have nothing to look forward to.
I feel that the future is hopeless and that things cannot improve.

3.

0
1
2
3

I do not feel like a failure.
I feel I have failed more than the average person.
As I look back on my life, all I can see is a lot of failures.
I feel I am a complete failure as a person.

4.

0
1
2
3

I get as much satisfaction out of things as I used to.
I don't enjoy things the way I used to.
I don't get real satisfaction out of anything anymore.
I am dissatisfied or bored with everything.

5.

0
1
2
3

I don't feel particularly guilty.
I feel guilty a good part of the time.
I feel quite guilty most of the time.
I feel guilty all of the time.

6.

0
1
2
3

I don't feel I am being punished.
I feel I may be punished.
I expect to be punished.
I feel I am being punished.

7.

0
1
2
3

I don't feel disappointed in myself.
I am disappointed in myself.
I am disgusted with myself.
I hate myself.
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8.

0
1
2
3

I don't feel I am worse than anybody else.
I am critical of myself for my weaknesses or mistakes.
I blame myself all the time for my faults.
I blame myself for everything bad that happens.

9.

0
1
2
3

I don't have any thoughts of killing myself.
I have thoughts of killing myself, but I would not carry them out.
I would like to kill myself.
I would kill myself if I had the chance.

10. 0
1
2
3

I don't cry any more than usual.
I cry more now than I used to.
I cry all the time now.
I used to be able to cry, but now I can't cry even though I want to.

11. 0
1
2
3

I am no more irritated now than I ever am.
I get annoyed or irritated more easily than I used to.
I feel irritated all the time now.
I don't get irritated at all by the things that used to irritate me.

12. 0
1
2
3

I have not lost interest in other people.
I am less interested in other people than I used to be.
I have lost most of my interest in other people.
I have lost all of my interest in other people.

13. 0
1
2
3

I make decisions about as well as I ever could.
I put off making decisions more than I used to.
I have greater difficulty in making decisions than before.
I can't make decisions at all anymore.

14. 0
1
2

I don't feel I look any worse than I used to.
I am worried that I am looking old or unattractive.
I feel that there are permanent changes in my appearance
that make me look unattractive.
I believe that I look ugly.

3
15. 0
1
2
3

I can work about as well as before.
It takes an extra effort to get started at doing something.
I have to push myself very hard to do anything.
I can't do any work at all.
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16. 0
1
2
3

I can sleep as well as usual.
I don't sleep as well as I used to.
I wake up 1-2 hours earlier than usual and find it hard to get back to
sleep.
I wake up several hours earlier than I used to and
cannot get back to sleep.

17. 0
1
2
3

I don't get tired more than usual.
I get tired more easily than I used to.
I get tired from doing almost anything.
I am too tired to do anything.

18. 0
1
2
3

My appetite is no worse than usual.
My appetite is not as good as it used to be.
My appetite is much worse now.
I have no appetite at all anymore.

19. 0
1
2
3

I haven't lost much weight, if any lately.
I have lost more than five pounds.
I have lost more than ten pounds.
I have lost more than fifteen pounds.
I am purposely trying to lose weight by eating less. Yes___ No____

20. 0
1
2
3

21. 0
1
2
3

I am no more worried about my health than usual.
I am worried about physical problems such as aches or
pains, or upset stomach,or constipation.
I am very worried about physical problems and it's hard
to think of much else.
I am so worried about my physical problems that I
cannot think about anything else.
I have not noticed any recent change in my interest in sex.
I am less interested in sex than I used to be.
I am much less interested in sex now.
I have lost interest in sex completely.
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